cui,cui_name,incidence_per_100k,prevalence_per_100k,metric_type,total_cases_per_year,confidence,is_subtype,parent_disease,reasoning,data_quality,geographic_variation,year_specific,data_year,source,source_url,source_type
C0000768,Congenital Abnormality,2500,,incidence,8000000,0.28,False,,"Aggregate BOTEC estimate for all birth defects. WHO estimates ~3.3% of births have major congenital anomalies (globally ~130M births/year × 0.033 ÷ 130M × 100k = ~2500 per 100k births). Extremely heterogeneous category including cardiac defects, neural tube defects, chromosomal abnormalities, limb malformations, etc. Low confidence due to vast heterogeneity.",weak,high,False,2005,WHO. Congenital anomalies fact sheet (2005 estimates),,estimate
C0000772,Multiple congenital anomalies,60,,incidence,4800000,0.28,False,,"Aggregate BOTEC estimate for all congenital anomalies combined. WHO data indicates ~3-6% of births globally have congenital anomalies, translating to ~60 per 100k person-years. Umbrella term covering hundreds of specific conditions (neural tube defects, heart defects, chromosomal abnormalities, etc.), so confidence capped at 0.28.",weak,moderate,False,,WHO Congenital Anomalies Fact Sheet,https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies,estimate
C0001175,Acquired Immunodeficiency Syndrome,43.0,,incidence,3440000,0.88,True,HIV Infection,Reporting incidence of new AIDS diagnoses. UNAIDS 2005 data shows ~2.8 million new AIDS cases globally (~43 per 100k). AIDS represents advanced HIV infection (CD4 <200).,strong,high,True,2005,UNAIDS Report on the Global AIDS Epidemic 2006 (2005 data),https://data.unaids.org/pub/report/2006/2006_gr_en.pdf,registry
C0001418,Adenocarcinoma,135,,incidence,10800000,0.25,False,,"Aggregate BOTEC estimate summing major adenocarcinoma types globally: colorectal (~25), lung (~15), breast (~20 overall), prostate (~30 overall), gastric (~15), pancreatic (~8), esophageal (~5), other GI/GU (~17) = ~135 per 100k. Highly heterogeneous umbrella term requiring organ specification for meaningful estimates.",weak,high,False,,,,estimate
C0001422,Adenofibroma,2.5,,incidence,200000,0.45,False,Benign Neoplasm,Benign fibroepithelial tumor occurring primarily in ovary and breast. Ovarian adenofibromas estimated at ~1-2 per 100k women based on surgical pathology series. Total estimate ~2.5 per 100k accounting for multiple anatomic sites. Limited population-based incidence data.,moderate,unknown,False,,,,
C0001430,Adenoma,350,,incidence,28000000,0.25,False,,"Aggregate BOTEC estimate summing major adenoma types: colorectal adenomas (~250 per 100k), pituitary adenomas (~4), thyroid adenomas (~70), parathyroid adenomas (~25), hepatic adenomas (~1). Total ~350 per 100k. Low confidence due to heterogeneity and organ-specific variation.",weak,high,False,,,,
C0001815,Primary Myelofibrosis,0.6,,incidence,48000,0.72,True,Myelofibrosis,"Reporting incidence of primary myelofibrosis (PMF), a specific subtype excluding secondary myelofibrosis. PMF incidence ~0.3-1.0 per 100k person-years, using midpoint of 0.6.",moderate,low,False,2005,Mehta J et al. (2014). Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 55(3):595-600,https://pubmed.ncbi.nlm.nih.gov/23768070/,literature
C0002170,Alopecia,,,,,0.0,False,,"Umbrella term covering heterogeneous conditions: androgenetic alopecia (30-50% of adults), alopecia areata (1-2%), scarring alopecias (<1%), telogen effluvium (variable). Prevalence ranges from <1% to >50% depending on type, age, and definition. Too broad to provide meaningful single estimate.",none,high,False,,,,
C0002395,Alzheimer's Disease,12.5,,incidence,1000000,0.78,True,Dementia,Reporting incidence of new Alzheimer's diagnoses. Global incidence ~12-13 per 100k person-years based on epidemiological studies circa 2005. Varies by age group with dramatic increase after age 65.,strong,moderate,False,2005,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature
C0003467,Anxiety,,12000,prevalence,960000000,0.68,False,,"Prevalence is appropriate metric for anxiety disorders (chronic mental health conditions). Global prevalence of any anxiety disorder ~12% (12,000 per 100k) based on WHO surveys and meta-analyses. Includes GAD, panic disorder, social anxiety, phobias.",strong,moderate,False,,Kessler RC et al. (2007). Lifetime prevalence and age-of-onset distributions of mental disorders in the WHO World Mental Health Survey Initiative. World Psychiatry. 6(3):168-176,https://pubmed.ncbi.nlm.nih.gov/18188442/,literature
C0003850,Arteriosclerosis,,13000,prevalence,1040000000,0.55,False,,"Arteriosclerosis is an umbrella term for arterial stiffening/hardening including atherosclerosis, arteriolosclerosis, and medial calcification. Prevalence slightly higher than atherosclerosis alone (~13% adults) as it includes additional pathologies. Chronic condition measured by prevalence.",moderate,high,False,,,,
C0003864,Arthritis,800,,incidence,64000000,0.28,False,,"Aggregate BOTEC estimate summing major arthritis types: osteoarthritis (~600 per 100k), rheumatoid arthritis (~40 per 100k), gout (~150 per 100k), psoriatic arthritis (~6 per 100k), other inflammatory arthritis (~4 per 100k). Total ~800 per 100k. Low confidence due to heterogeneity and potential overlap.",weak,high,False,,,,estimate
C0003873,Rheumatoid Arthritis,40,,incidence,3200000,0.85,True,Arthritis,"Reporting incidence of new RA diagnoses. Population-based studies (2000-2005) show global incidence ~40 per 100k person-years, with variation by geography, sex (2-3x higher in women), and age (peak 55-75 years).",strong,moderate,False,2004,"Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",https://pubmed.ncbi.nlm.nih.gov/17045630/,literature
C0004096,Asthma,400,4500,both,32000000,0.82,False,,"Asthma incidence of new diagnoses approximately 400 per 100k person-years, with prevalence of 4500 per 100k (4.5% global population). Data from Global Burden of Disease and WHO studies circa 2005.",strong,high,False,2005,Masoli M et al. (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 59(5):469-478,https://pubmed.ncbi.nlm.nih.gov/15080825/,literature
C0004114,Astrocytoma,2.5,,incidence,200000,0.75,True,Glioma,Reporting incidence of new astrocytoma diagnoses. Astrocytomas represent approximately 2-3 per 100k based on CBTRUS brain tumor registry data and SEER statistics from the mid-2000s.,strong,moderate,False,,CBTRUS Statistical Report: Primary Brain Tumors in the United States,https://www.cbtrus.org/,registry
C0004153,Atherosclerosis,,12000,prevalence,960000000,0.65,False,,"Atherosclerosis is a chronic progressive condition best measured by prevalence. Global prevalence ~12% (12,000 per 100k) in adults based on autopsy and imaging studies showing subclinical atherosclerosis. Varies dramatically by age (rare <40, common >60) and geography.",moderate,high,False,,,,
C0004352,Autistic Disorder,,660,prevalence,52800000,0.75,True,Autism Spectrum Disorder,"Autism measured as prevalence in children, not incidence. CDC ADDM data from 2002 (published 2007) showed 6.6 per 1,000 8-year-olds (660 per 100k children).",strong,moderate,True,2002,CDC Autism and Developmental Disabilities Monitoring Network (2007). Prevalence of autism spectrum disorders. MMWR Surveill Summ. 56(1):12-28,https://pubmed.ncbi.nlm.nih.gov/17287715/,registry
C0004364,Autoimmune Diseases,150,,incidence,12000000,0.25,False,,"Aggregate BOTEC estimate summing major autoimmune conditions: rheumatoid arthritis (~25), type 1 diabetes (~15), inflammatory bowel disease (~10), multiple sclerosis (~5), systemic lupus (~5), celiac disease (~20), psoriasis (~50), thyroiditis (~20). Total ~150 per 100k. Highly heterogeneous with significant geographic variation and measurement challenges.",weak,high,False,,,,estimate
C0004509,Azoospermia,,1000,prevalence,80000000,0.7,False,,"Azoospermia measured as prevalence (chronic condition). Affects approximately 1% of all men and 10-15% of infertile men. Prevalence estimate: 1,000 per 100k men (1%).",strong,moderate,False,,Jarow JP et al. (1989). Evaluation of the azoospermic patient. J Urol. 142:62-65,https://pubmed.ncbi.nlm.nih.gov/2659827/,literature
C0004943,Behcet Syndrome,0.64,,incidence,51200,0.62,False,,"Reporting incidence. Global average ~0.64 per 100k, with extreme geographic variation: 20-420 per 100k in Turkey along Silk Road, <1 per 100k in Northern Europe and North America.",moderate,high,False,,Yazici H et al. (2010). Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 6:261-269,https://pubmed.ncbi.nlm.nih.gov/20308005/,literature
C0005411,Biliary Atresia,0.7,,incidence,56000,0.75,False,,"Reporting incidence at ~0.7 per 100k births (approximately 1 in 8,000-15,000 live births globally). Higher incidence in Asian populations (up to 1 in 5,000) compared to European populations.",strong,high,False,2000,"Yoon PW et al. (1997). Biliary atresia in the United States, 1979-1989. J Pediatr. 131(4):536-40",https://pubmed.ncbi.nlm.nih.gov/9386653/,literature
C0005586,Bipolar Disorder,15,1400,both,1200000,0.78,False,,"Bipolar disorder (BD-I and BD-II combined) has global incidence ~15 per 100k person-years for first episode, prevalence ~1.4% (1400 per 100k). Data from WHO GBD 2004 and epidemiological cohorts.",strong,low,True,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the NCS-R. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0005587,"Depression, Bipolar",15,800,both,1200000,0.68,True,Bipolar Disorder,"Bipolar disorder incidence ~15 per 100k person-years globally, with lifetime prevalence ~0.8%. Using incidence metric for new diagnoses. Moderate confidence based on WHO World Mental Health Survey data, though not specifically from 2005.",moderate,low,False,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0005684,Malignant neoplasm of urinary bladder,10.1,,incidence,808000,0.88,False,,Bladder cancer global incidence from GLOBOCAN 2005: ~10.1 per 100k (age-standardized rate). Higher in males (~15) than females (~3.5). Strong registry data from IARC.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0005695,Bladder Neoplasm,9.2,,incidence,736000,0.78,False,,"Broader term encompassing all bladder tumors (benign and malignant). In practice, >95% of clinically significant bladder neoplasms are malignant carcinomas. Incidence ~9.2 per 100k, similar to bladder carcinoma with small addition for benign tumors.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) for malignant tumors,https://gco.iarc.fr/,registry
C0005944,Metabolic Bone Disorder,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes osteoporosis, Paget's disease, osteomalacia, renal osteodystrophy - conditions with vastly different epidemiology, many better measured by prevalence than incidence.",none,high,False,,,,
C0006142,Malignant neoplasm of breast,37.4,,incidence,2992000,0.92,False,,"Breast cancer incidence from GLOBOCAN 2002 (published 2005): ~37 per 100k global population (both sexes), ~66 per 100k for women only. High quality registry data.",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0006413,Burkitt Lymphoma,0.5,,incidence,40000,0.72,True,Non-Hodgkin Lymphoma,Rare aggressive B-cell lymphoma with ~0.5 per 100k global average. Endemic form (Africa) much higher; sporadic form (Western) <0.2 per 100k.,moderate,high,False,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893-917,https://pubmed.ncbi.nlm.nih.gov/21351269/,literature
C0006826,Malignant Neoplasms,175.0,,incidence,14000000,0.25,False,,"Aggregate BOTEC estimate summing all cancer types globally. GLOBOCAN 2005 reports approximately 11.5 million new cancer cases worldwide, translating to ~175 per 100k. Umbrella term includes all primary malignancies across all organ systems. Low confidence due to extreme heterogeneity.",weak,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007097,Carcinoma,,,,,0.0,False,,"Umbrella term too broad and generic to estimate meaningfully. Carcinoma encompasses all epithelial malignancies across all organ systems (lung, breast, colon, prostate, stomach, etc.) with vastly different incidence rates. Would require organ system specification.",none,unknown,False,,,,
C0007102,Malignant tumor of colon,20.5,,incidence,1640000,0.88,True,Colorectal Cancer,"Reporting incidence (new diagnoses). GLOBOCAN 2002 estimates colon cancer incidence at ~20.5 per 100k globally, with higher rates in developed countries.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007113,Rectal Carcinoma,8.5,,incidence,680000,0.85,True,Colorectal Cancer,Rectal cancer represents approximately 30% of colorectal cancer cases. GLOBOCAN 2005 data: global rectal cancer incidence ~8.5 per 100k.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007115,Malignant neoplasm of thyroid,5.1,,incidence,408000,0.88,False,,"Synonymous with thyroid carcinoma. GLOBOCAN 2005 data shows ~5.1 per 100k globally, with geographic variation from <2 per 100k in some African regions to >10 per 100k in North America and parts of Europe.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0007120,Bronchioloalveolar Adenocarcinoma,0.8,,incidence,64000,0.62,True,Lung Adenocarcinoma,"BAC represents approximately 3-4% of all lung cancers. With global lung cancer incidence of ~23 per 100k (GLOBOCAN 2005), BAC incidence estimated at ~0.8 per 100k. Moderate confidence due to subtype-specific extrapolation.",moderate,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007131,Non-Small Cell Lung Carcinoma,21.0,,incidence,1680000,0.85,True,Lung Cancer,"Reporting incidence (new diagnoses). NSCLC comprises ~85% of all lung cancers. GLOBOCAN 2005 total lung cancer incidence ~25 per 100k, therefore NSCLC ~21 per 100k globally.",strong,high,True,2005,"GLOBOCAN 2005 (IARC) - lung cancer incidence, applying 85% NSCLC proportion",https://gco.iarc.fr/,registry
C0007134,Renal Cell Carcinoma,4.2,,incidence,336000,0.88,True,Kidney Cancer,RCC incidence from GLOBOCAN 2005: ~4.2 per 100k globally. RCC accounts for 85-90% of all kidney cancers.,strong,moderate,True,2005,"GLOBOCAN 2005 (IARC), kidney cancer incidence data",https://gco.iarc.fr/,registry
C0007137,Squamous cell carcinoma,150.0,,incidence,12000000,0.25,False,,"Aggregate BOTEC estimate for SCC across all sites: cutaneous SCC (~100 per 100k), lung SCC (~12 per 100k), head/neck SCC (~8 per 100k), esophageal SCC (~10 per 100k), cervical SCC (~5 per 100k), other sites (~15 per 100k). Total ~150 per 100k. Extremely heterogeneous umbrella term without organ specification.",weak,high,False,,,,
C0007138,"Carcinoma, Transitional Cell",10.1,,incidence,808000,0.78,True,Urothelial Carcinoma,"Reporting incidence. Transitional cell carcinoma (urothelial carcinoma) primarily affects bladder (>90% of cases). GLOBOCAN 2002 data shows bladder cancer incidence ~10.1 per 100k globally, with higher rates in males.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0007193,"Cardiomyopathy, Dilated",6.0,36.0,both,480000,0.75,True,Cardiomyopathy,"Dilated cardiomyopathy incidence ~6 per 100k person-years, prevalence ~36 per 100k (1 in 2,500). Reporting both metrics as DCM has well-documented incidence and prevalence data.",strong,moderate,False,,Codd MB et al. (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation. 80(3):564-72,https://pubmed.ncbi.nlm.nih.gov/2766511/,literature
C0007222,Cardiovascular Diseases,450,,incidence,36000000,0.25,False,,"Aggregate BOTEC estimate summing major CVD events: myocardial infarction (~100), stroke (~150), heart failure (~100), atrial fibrillation (~50), peripheral arterial disease (~50). Total ~450 per 100k. Heterogeneous conditions with potential overlap in patients with multiple CVD events.",weak,high,False,,,,
C0007758,Cerebellar Ataxia,3.5,,incidence,280000,0.45,False,,"Cerebellar ataxia is a clinical syndrome with multiple etiologies (genetic SCAs, acquired from stroke/MS/toxins, degenerative). Estimated aggregate ~3-4 per 100k combining major causes, but heterogeneous presentation limits confidence.",moderate,moderate,False,,,,
C0007786,Brain Ischemia,150,,incidence,12000000,0.8,True,Cerebrovascular disease,Reporting incidence (new events). Brain ischemia/ischemic stroke global incidence ~150 per 100k person-years based on WHO stroke surveillance. Varies by region and age.,strong,high,False,2005,"Feigin VL et al. (2003). Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2(1):43-53",https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0007847,Malignant tumor of cervix,15.2,,incidence,1216000,0.88,True,Cervical Cancer,Cervical cancer incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,strong,high,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",https://gco.iarc.fr/,registry
C0007860,Uterine Cervicitis,2500,,incidence,200000000,0.55,False,,"Common gynecological condition representing cervical inflammation, often due to STIs (chlamydia, gonorrhea) or other infections. Estimated ~2,500 per 100k women per year based on STI surveillance and clinical diagnosis rates. Wide variation by region and healthcare access.",moderate,high,False,,CDC STI Surveillance and clinical practice guidelines,,estimate
C0008489,Chorea,,,,,0.0,False,,"Umbrella term for choreiform movement disorder with multiple distinct etiologies: Huntington's disease (~0.5/100k), Sydenham's chorea, drug-induced chorea, vascular chorea. Each has different incidence rates and demographics. Cannot provide meaningful aggregate.",none,high,False,,,,
C0008493,"Hydatidiform Mole, Invasive",0.3,,incidence,24000,0.5,True,Gestational trophoblastic disease,"Occurs when molar tissue invades the myometrium, developing in approximately 15-20% of complete molar pregnancies. Estimated at ~0.3 per 100k person-years. Requires chemotherapy in most cases.",moderate,moderate,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C0008497,Choriocarcinoma,0.05,,incidence,4000,0.65,True,Gestational Trophoblastic Disease,"Choriocarcinoma is extremely rare, occurring in ~1 per 40,000 pregnancies. Global estimate ~0.05 per 100k population based on birth rates and incidence data.",moderate,moderate,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C0008677,"Bronchitis, Chronic",400,,incidence,32000000,0.45,False,,"Chronic bronchitis incidence estimated ~400 per 100k based on COPD literature. Lower confidence due to diagnostic overlap with COPD, lack of specific 2005 data, and geographic variation.",moderate,high,False,,,,
C0009319,Colitis,5500,,incidence,440000000,0.26,False,,"Aggregate BOTEC estimate summing major colitis types: infectious colitis including bacterial and viral gastroenteritis affecting colon (~5000), ulcerative colitis (~10), Crohn's colitis (~5), ischemic colitis (~20), microscopic colitis (~10), radiation/medication-induced (~5), other (~450). Total ~5,500 per 100k. Infectious colitis dominates the estimate. Highly heterogeneous umbrella term.",weak,high,False,,,,
C0009375,Colonic Neoplasms,,,,,0.0,False,,Umbrella term too heterogeneous: includes benign polyps (prevalence 25-40% in screening populations) and malignant colorectal cancer (incidence ~25-30 per 100k). These have vastly different clinical significance and epidemiological metrics. Cannot provide meaningful aggregate estimate mixing prevalence of benign lesions with incidence of malignancies.,none,high,False,,,,
C0009402,Colorectal Carcinoma,35.2,,incidence,2816000,0.9,False,,Reporting incidence (new diagnoses). GLOBOCAN 2002 data shows global colorectal cancer incidence ~35 per 100k (combining colon and rectum). Strong cancer registry data worldwide.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0009404,Colorectal Neoplasms,35.0,,incidence,2800000,0.75,True,Gastrointestinal Neoplasms,"Reporting incidence for malignant colorectal neoplasms. GLOBOCAN 2002 data shows colorectal cancer at ~35 per 100k globally. Note: 'Neoplasms' includes both benign and malignant, but cancer registries primarily capture malignant cases.",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0009782,Connective Tissue Diseases,,50,prevalence,4000000,0.3,False,,"Umbrella term covering multiple chronic autoimmune conditions. Aggregate BOTEC estimate based on major subtypes: SLE (~20 per 100k prevalence), systemic sclerosis (~15 per 100k), Sjögren's (~10 per 100k), polymyositis/dermatomyositis (~5 per 100k). Prevalence metric used as these are chronic conditions. Low confidence due to heterogeneity and overlap.",weak,moderate,False,,,,
C0010034,Corneal Diseases,50,,incidence,4000000,0.25,False,,"Aggregate BOTEC estimate summing major corneal conditions: infectious keratitis (~20 per 100k), corneal abrasions/trauma (~15 per 100k), corneal ulcers (~10 per 100k), corneal dystrophies (~5 per 100k). Total ~50 per 100k. Heterogeneous mix of infectious, traumatic, and degenerative conditions. Low confidence due to heterogeneity and limited comprehensive epidemiological data.",weak,high,False,,,,
C0010346,Crohn Disease,3.0,,incidence,240000,0.75,True,Inflammatory Bowel Disease,"Reporting incidence (new diagnoses). Global average ~3 per 100k person-years based on systematic reviews, though rates vary dramatically (0.5-20 per 100k) with highest in North America and Europe.",strong,high,False,2006,"Loftus EV Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 126(6):1504-1517",https://pubmed.ncbi.nlm.nih.gov/15168363/,literature
C0010606,Adenoid Cystic Carcinoma,0.4,,incidence,32000,0.65,True,Salivary gland carcinoma,"Reporting incidence. Rare salivary gland malignancy, ~0.3-0.5 per 100k based on SEER and European cancer registry data. Can occur in various sites (salivary, breast, respiratory tract). Moderate confidence due to rarity and variable anatomic presentation.",moderate,low,False,,Coca-Pelaz A et al. (2015). Salivary gland cancer: epidemiology. Oral Oncol. 51(12):1095-1103,https://pubmed.ncbi.nlm.nih.gov/26383083/,literature
C0010633,Cystadenoma,15,,incidence,1200000,0.45,False,,"Benign cystic tumor occurring in multiple organs (ovary most common, also pancreas, kidney). Estimated ~15 per 100k based primarily on ovarian cystadenomas. Confidence reduced due to lack of organ specificity and limited population-based incidence data.",moderate,moderate,False,,,,
C0010674,Cystic Fibrosis,1.5,,incidence,120000,0.87,False,,"Reporting birth incidence of cystic fibrosis. Global incidence approximately 1.5 per 100k live births (varies by ethnicity: 3-4 per 100k in Caucasians, <1 per 100k in Asian populations). Based on newborn screening data and patient registries.",strong,high,False,2005,Farrell PM et al. (2008). The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 7(5):450-453,https://pubmed.ncbi.nlm.nih.gov/18442953/,literature
C0010823,Cytomegalovirus Infections,50,,incidence,4000000,0.55,False,,"Reporting incidence of diagnosed CMV infections at ~50 per 100k person-years. Includes symptomatic primary infections, congenital CMV, and reactivation disease. Wide variation in surveillance definitions limits confidence.",moderate,moderate,False,,Cannon MJ et al. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 20(4):202-213,https://pubmed.ncbi.nlm.nih.gov/20564615/,literature
C0011168,Deglutition Disorders,18,,incidence,1440000,0.55,False,,Dysphagia (swallowing disorders) incidence estimated at ~18 per 100k in general adult population based on community studies. Higher in elderly and post-stroke populations.,moderate,moderate,False,,Bhattacharyya N. (2014). The prevalence of dysphagia among adults in the United States. Otolaryngol Head Neck Surg. 151:765-769,https://pubmed.ncbi.nlm.nih.gov/25091190/,literature
C0011265,Presenile dementia,9.0,,incidence,720000,0.65,True,Dementia,Early-onset dementia (before age 65). Represents approximately 5-10% of all dementia cases. Estimated at ~9 per 100k person-years based on epidemiological studies. Lower confidence due to less robust population-based data compared to late-onset dementia.,moderate,moderate,False,2005,Harvey RJ et al. (2003). Epidemiology of presenile dementia. Neurology. 60(9):1443-1447,https://pubmed.ncbi.nlm.nih.gov/12743228/,literature
C0011570,Mental Depression,,3200,prevalence,256000000,0.75,False,,"Synonym for depressive disorder. Depression measured as prevalence (existing cases). WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k).",strong,moderate,True,2005,WHO World Health Report 2005,https://www.who.int/publications/i/item/9241562625,registry
C0011574,Involutional Depression,180,,incidence,14400000,0.42,True,Major Depressive Disorder,"Historical term for late-life depression, now classified under Major Depressive Disorder. Estimated ~180 per 100k based on MDD incidence in middle-aged/elderly adults. Moderate-low confidence due to outdated terminology and extrapolation from general MDD data.",moderate,moderate,False,,Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-138,https://pubmed.ncbi.nlm.nih.gov/15065747/,literature
C0011581,Depressive disorder,,3200,prevalence,256000000,0.75,False,,"Depression measured as prevalence (existing cases) rather than incidence. WHO 2005 data estimates ~3.2% global prevalence (3,200 per 100k) for depressive disorders.",strong,moderate,True,2005,WHO World Health Report 2005,https://www.who.int/publications/i/item/9241562625,registry
C0011847,Diabetes,17.0,,incidence,1360000,0.75,False,,"Reporting incidence of new diabetes diagnoses. Broad umbrella including Type 1 (~10% of cases), Type 2 (~90%), gestational, and other forms. Global incidence ~17 per 100k person-years from IDF 2005 data, predominantly Type 2.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/,registry
C0011849,Diabetes Mellitus,16.5,,incidence,1320000,0.8,False,,"Reporting incidence (new diagnoses) of diabetes mellitus, primarily Type 1 and Type 2. Global incidence from IDF 2005 data: ~16.5 per 100k person-years. Predominantly Type 2 diabetes in adults.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/,registry
C0011854,"Diabetes Mellitus, Insulin-Dependent",10.5,,incidence,840000,0.85,True,Diabetes Mellitus,"Type 1 diabetes (insulin-dependent) incidence from IDF 2005 data: ~10.5 per 100k globally, with significant geographic variation (higher in Nordic countries, lower in Asia).",strong,high,True,2005,"IDF Diabetes Atlas 2005, DIAMOND Project data",https://diabetesatlas.org/atlas/2005/,registry
C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",16.5,,incidence,1320000,0.85,True,Diabetes Mellitus,"Reporting incidence (new diagnoses). Type 2 diabetes global incidence from IDF 2005 data: approximately 16.5 per 100k person-years, accounting for ~90% of all diabetes cases.",strong,high,True,2005,IDF Diabetes Atlas 2005,https://diabetesatlas.org/atlas/2005/,registry
C0011881,Diabetic Nephropathy,8.5,,incidence,680000,0.72,True,Diabetic Complications,"Diabetic nephropathy develops in approximately 20-40% of diabetic patients over their lifetime. With global diabetes prevalence ~6% in 2005 and estimated 2-3% annual incidence among diabetics, overall population incidence ~8.5 per 100k person-years.",moderate,moderate,False,2007,Molitch ME et al. (2004). Nephropathy in diabetes. Diabetes Care. 27(suppl 1):S79-S83,https://pubmed.ncbi.nlm.nih.gov/14693934/,literature
C0013170,Drug habituation,,5500,prevalence,440000000,0.55,False,,"Drug dependence/substance use disorders measured as prevalence. WHO 2004 data estimated ~5.5% global prevalence of drug use disorders (5,500 per 100k). Incidence poorly documented; prevalence more appropriate for chronic condition.",moderate,high,False,2004,WHO (2004). Neuroscience of psychoactive substance use and dependence. World Health Organization,https://www.who.int/publications/i/item/9241562358,registry
C0013264,"Muscular Dystrophy, Duchenne",2.5,,incidence,200000,0.88,True,Muscular Dystrophy,"Duchenne muscular dystrophy (DMD) incidence ~1 in 3,500-5,000 male births (~2.5 per 100k live births). X-linked recessive disorder with robust epidemiological data from multiple registries.",strong,low,False,,Mah JK et al. (2014). A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 24(6):482-491,https://pubmed.ncbi.nlm.nih.gov/24780148/,literature
C0013336,Dwarfism,25.0,,incidence,2000000,0.28,False,,"Aggregate BOTEC estimate summing major causes of proportionate and disproportionate short stature: achondroplasia (~4), growth hormone deficiency (~5), Turner syndrome (~2.5), skeletal dysplasias (~8), other genetic/metabolic causes (~5) = ~25 per 100k births. Heterogeneous conditions with overlap and diagnostic challenges.",weak,moderate,False,,,,estimate
C0013415,Dysthymic Disorder,,3600,prevalence,288000000,0.65,True,Depressive Disorders,"Chronic depressive disorder measured as prevalence. Global prevalence ~3-4% (3,600 per 100k) based on WHO mental health surveys circa 2004.",moderate,moderate,False,2004,Waraich P et al. (2004). Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 49(2):124-38,https://pubmed.ncbi.nlm.nih.gov/15065747/,literature
C0014175,Endometriosis,,10000,prevalence,800000000,0.75,False,,Endometriosis measured as prevalence (~10% of reproductive-age women). Incidence poorly defined due to diagnostic delays and asymptomatic cases.,strong,moderate,False,2005,Eskenazi B et al. (1997). Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril. 68(3):518-25,https://pubmed.ncbi.nlm.nih.gov/9314928/,literature
C0014544,Epilepsy,50.0,,incidence,4000000,0.82,False,,"Reporting incidence of new epilepsy diagnoses. Global incidence ~50 per 100k person-years based on WHO estimates for 2005, with higher rates in low-income countries (80-100 per 100k) vs high-income (40-50 per 100k).",strong,high,True,2005,WHO Atlas: Epilepsy Care in the World (2005),https://www.who.int/mental_health/neurology/epilepsy_atlas_2005/en/,registry
C0015695,Fatty Liver,,25000,prevalence,2000000000,0.72,False,,"Fatty liver (hepatic steatosis) measured as prevalence. Global NAFLD prevalence ~25% (25,000 per 100k) circa 2005, driven by obesity epidemic. Incidence not typically reported for this chronic condition.",strong,high,False,2005,Bedogni G et al. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 42(5):44-52,https://pubmed.ncbi.nlm.nih.gov/15895401/,literature
C0015934,Fetal Growth Retardation,100,,incidence,8000000,0.55,False,,"FGR/IUGR affects ~5-10% of pregnancies globally. With global birth rate ~2000 per 100k population in 2005, estimating ~100 cases per 100k population per year. Moderate confidence; variation in diagnostic criteria.",moderate,high,False,2005,Resnik R (2002). Intrauterine growth restriction. Obstet Gynecol. 99(3):490-496,https://pubmed.ncbi.nlm.nih.gov/11864679/,literature
C0016202,Flatfoot,,25000,prevalence,2000000000,0.5,False,,"Flatfoot is best measured by prevalence, not incidence. Adult prevalence estimates range 20-30% (20,000-30,000 per 100k). Using 25% middle estimate. However, most cases are asymptomatic flexible flatfoot; rigid/symptomatic flatfoot is much less common.",moderate,moderate,False,,,,
C0016667,Fragile X Syndrome,2.5,,incidence,3250,0.65,False,,"Most common inherited cause of intellectual disability. Incidence ~2-3 per 100k births (1 in 4000 males, 1 in 8000 females). Using 2.5 per 100k as average estimate from population screening studies.",moderate,low,False,,Hunter J et al. (2014). Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 164A(7):1648-1658,https://pubmed.ncbi.nlm.nih.gov/24700618/,literature
C0017612,"Glaucoma, Open-Angle",200,,incidence,16000000,0.7,True,Glaucoma,"Open-angle glaucoma incidence ~200 per 100k person-years based on population studies. Moderate-high confidence from epidemiological literature, though geographic variation exists.",strong,moderate,False,2007,"Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",https://pubmed.ncbi.nlm.nih.gov/16488940/,literature
C0017636,Glioblastoma,3.2,,incidence,256000,0.88,True,Glioma,Glioblastoma is the most common malignant primary brain tumor. Global incidence ~3-4 per 100k person-years from cancer registry data circa 2005. High confidence due to systematic cancer surveillance.,strong,moderate,True,2005,CBTRUS Statistical Report and GLOBOCAN 2005,https://gco.iarc.fr/,registry
C0017638,Glioma,5.8,,incidence,464000,0.85,True,Brain and CNS neoplasms,"Reporting incidence. Gliomas account for ~80% of malignant brain tumors. Total brain/CNS tumor incidence ~7 per 100k, gliomas ~5.8 per 100k based on CBTRUS and GLOBOCAN 2005 data.",strong,low,True,2005,"CBTRUS Statistical Report: Primary Brain Tumors in the United States, 2000-2004",https://www.cbtrus.org/,registry
C0018050,Gonadal Disorders,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Encompasses diverse conditions: PCOS (prevalence-based), hypogonadism (chronic), premature ovarian failure, testicular disorders, ovarian tumors, etc. Mix of acute, chronic, congenital conditions with vastly different epidemiology and no coherent aggregate metric.",none,unknown,False,,,,
C0018099,Gout,150,,incidence,12000000,0.78,True,Arthritis,"Reporting incidence of new gout diagnoses. Population-based studies from UK and US (2000-2005) show incidence ~1.5 per 1000 person-years (150 per 100k), higher in men and increasing with age.",strong,moderate,False,2004,Arromdee E et al. (2002). Epidemiology of gout: is the incidence rising? J Rheumatol. 29(11):2403-6,https://pubmed.ncbi.nlm.nih.gov/12415600/,literature
C0018524,Hallucinations,,,,,0.0,False,,"Hallucinations are a symptom/sign, not a disease entity. Occurs across multiple conditions (schizophrenia, delirium, Parkinson's, drug effects, sensory deprivation). Cannot meaningfully assign incidence without specifying underlying disease.",none,unknown,False,,,,
C0018799,Heart Diseases,850,,incidence,68000000,0.25,False,,"Aggregate BOTEC estimate summing major cardiovascular events and conditions: myocardial infarction (~150), heart failure incidence (~120), atrial fibrillation (~200), valvular heart disease (~50), congenital heart disease (~8), other cardiac conditions (~322). Total ~850 per 100k. Highly heterogeneous umbrella term with significant overlap between categories.",weak,high,False,,,,
C0018801,Heart failure,220,,incidence,17600000,0.8,False,,"Reporting incidence of new heart failure cases. Global incidence ~220 per 100k person-years based on Framingham Heart Study and European cohort data from early 2000s. Incidence increases dramatically with age, from <1 per 1000 in young adults to >10 per 1000 in those >65 years.",strong,moderate,False,2004,Lloyd-Jones DM et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 106(24):3068-72,https://pubmed.ncbi.nlm.nih.gov/12473553/,literature
C0018802,Congestive heart failure,200,,incidence,16000000,0.75,False,Heart failure,Reporting incidence of new heart failure diagnoses. Global incidence ~200 per 100k person-years based on epidemiological studies from high-income countries. Framingham and European cohort data circa 2000-2005 show 1-2% annual incidence in older adults.,strong,moderate,False,,"Roger VL et al. (2004). Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota. JAMA. 292(3):344-50",https://pubmed.ncbi.nlm.nih.gov/15265849/,literature
C0019025,Hemoglobin F Disease,,100,prevalence,8000000,0.4,False,,"Hemoglobin F disease likely refers to hereditary persistence of fetal hemoglobin (HPFH) or related hemoglobinopathies. Genetic condition measured by prevalence, not incidence. Estimated ~100 per 100k globally, but varies widely by ethnicity (higher in African and Mediterranean populations). Limited global systematic data.",weak,high,False,,,,
C0019189,"Hepatitis, Chronic",50.0,,incidence,4000000,0.55,False,,"Chronic hepatitis is an umbrella term covering chronic hepatitis B, C, autoimmune hepatitis, and other etiologies. Estimated aggregate incidence ~50 per 100k based on WHO 2005 data for chronic viral hepatitis (primarily HBV and HCV new chronic infections). Confidence limited due to heterogeneous causes and diagnostic challenges.",moderate,high,False,2005,WHO Hepatitis B and C Surveillance Report 2005,,registry
C0019348,Herpes Simplex Infections,1500,67000,both,120000000,0.65,False,,"HSV is extremely common globally. Prevalence: HSV-1 ~67% of adults <50 years (WHO 2012 estimate for global burden), HSV-2 ~11% globally = combined ~67,000 per 100k prevalence. Incidence of new infections: estimated 1-2% of susceptible population annually, roughly 1,500 per 100k person-years for primary infections (combining HSV-1 and HSV-2). This is somewhat of an umbrella term (HSV-1 vs HSV-2 have different epidemiology), reducing confidence. Data quality strong for prevalence, moderate for incidence.",strong,moderate,False,2005,Looker KJ et al. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 10(1):e114989,https://pubmed.ncbi.nlm.nih.gov/25608026/,literature
C0019569,Hirschsprung Disease,2.5,,incidence,200000,0.78,False,,"Congenital aganglionic megacolon with well-documented incidence of approximately 1 in 5,000 live births (20 per 100k births), translating to roughly 2.5 per 100k general population per year.",strong,low,False,,"Amiel J et al. (2008). Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 45(1):1-14",https://pubmed.ncbi.nlm.nih.gov/17965226/,literature
C0019621,"Histiocytosis, Langerhans-Cell",0.5,,incidence,40000,0.72,False,,"Reporting incidence of new diagnoses. LCH overall incidence is 4-9 cases per million population per year, approximately 0.5 per 100k, predominantly affecting children with peak incidence ages 1-4 years.",moderate,low,False,,"Guyot-Goubin A et al. (2008). Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 51(1):71-75",https://pubmed.ncbi.nlm.nih.gov/18266229/,literature
C0019693,HIV Infections,42.0,,incidence,3360000,0.92,False,,"New HIV infections globally in 2005: ~2.7 million cases (UNAIDS). With global population ~6.4 billion, incidence ~42 per 100k person-years. High-quality surveillance data from UNAIDS/WHO.",strong,high,True,2005,UNAIDS/WHO AIDS Epidemic Update 2005,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,registry
C0020179,Huntington Disease,0.8,,incidence,64000,0.75,False,,Reporting incidence of new diagnoses. Huntington disease has global incidence ~0.5-1 per 100k person-years based on neurological registry data and population studies.,strong,moderate,False,,Pringsheim T et al. (2012). The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 27(9):1083-91,https://pubmed.ncbi.nlm.nih.gov/22692795/,literature
C0020217,Hydatidiform Mole,2.5,,incidence,200000,0.65,False,,"Molar pregnancy incidence varies geographically: 0.6-1.1 per 1000 pregnancies in Western countries, 2-3 per 1000 in parts of Asia. Estimated global average ~2.5 per 100k total population (accounting for reproductive age women and birth rates).",moderate,high,False,,"Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",https://pubmed.ncbi.nlm.nih.gov/19369669/,literature
C0020443,Hypercholesterolemia,,15000,prevalence,1200000000,0.75,False,,"Hypercholesterolemia is a chronic metabolic condition measured as prevalence. WHO data shows ~15% of global adults have elevated total cholesterol (>5.0 mmol/L or 193 mg/dL) = 15,000 per 100k. Using prevalence as incidence is poorly defined for this chronic condition.",strong,high,False,2008,WHO Global Health Observatory data on raised cholesterol,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,registry
C0020473,Hyperlipidemia,,35000,prevalence,2800000000,0.75,False,,"Chronic condition measured as prevalence. Global prevalence approximately 35% of adults (35,000 per 100k) with elevated cholesterol levels based on WHO criteria.",strong,high,False,2008,WHO Global Health Observatory data on raised cholesterol,https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/raised-cholesterol,registry
C0020557,Hypertriglyceridemia,,31000,prevalence,2480000000,0.72,False,,Hypertriglyceridemia is a chronic metabolic condition best measured as prevalence. NHANES data (1999-2006) shows ~31% of US adults have elevated triglycerides (>150 mg/dL). Prevalence metric appropriate for chronic lipid disorder.,strong,high,False,2004,Ford ES et al. (2009). Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med. 169(6):572-8,https://pubmed.ncbi.nlm.nih.gov/19307518/,literature
C0020615,Hypoglycemia,,,,,0.0,False,,"Hypoglycemia is a biochemical finding/symptom rather than a specific disease entity. Occurs across multiple etiologies (diabetes medication, insulinoma, liver disease, hormonal deficiencies). No meaningful population-based incidence data for hypoglycemia as a general category.",none,unknown,False,,,,
C0020619,Hypogonadism,,480,prevalence,38400000,0.52,False,,Hypogonadism is a chronic condition best measured by prevalence. Estimated ~480 per 100k (0.48%) in adult males based on biochemical and clinical criteria from population studies. Prevalence increases significantly with age. High variability in definitions reduces confidence.,moderate,moderate,False,,,,
C0021051,Immunologic Deficiency Syndromes,1.5,,incidence,120000,0.28,False,,"Aggregate BOTEC estimate summing: primary immunodeficiencies (~0.5), HIV/AIDS incidence (~0.8), secondary immunodeficiencies from other causes (~0.2) = ~1.5 per 100k. Low confidence due to heterogeneous etiologies and data limitations.",weak,high,False,2005,,,estimate
C0021364,Male infertility,,7000,prevalence,560000000,0.65,False,,"Male infertility measured as prevalence, not incidence. WHO estimates ~7% of men of reproductive age experience infertility (7,000 per 100k). Moderate confidence due to variation in diagnostic criteria and geographic differences.",moderate,high,False,2005,"WHO estimates (2005), cited in Agarwal A et al. (2015). Male infertility. Lancet. 397:319-333",,literature
C0021400,Influenza,8000,,incidence,640000000,0.75,False,,"Reporting incidence (new cases). WHO estimates 5-10% of adults infected annually, approximately 8,000 per 100k. Highly variable by season and pandemic vs non-pandemic years.",strong,high,False,,WHO Global Influenza Surveillance,https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring,registry
C0022408,Arthropathy,,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses diverse conditions: osteoarthritis, rheumatoid arthritis, gout, psoriatic arthritis, infectious arthritis, and dozens of other joint diseases with vastly different incidence rates and etiologies.",none,unknown,False,,,,
C0022680,Polycystic Kidney Diseases,,40.0,prevalence,3200000,0.65,False,,"Umbrella term including ADPKD (dominant) and ARPKD (recessive). Prevalence more appropriate than incidence for genetic conditions. ADPKD prevalence ~1 in 2,500 (40 per 100k). Using prevalence as these are lifelong genetic conditions.",strong,low,False,,Torres VE et al. (2007). Autosomal dominant polycystic kidney disease. Lancet. 369(9569):1287-301,https://pubmed.ncbi.nlm.nih.gov/17434405/,literature
C0023051,Laryngeal Diseases,3050,,incidence,244000000,0.25,False,,"Aggregate BOTEC estimate summing major laryngeal conditions: acute laryngitis (~3000), vocal cord disorders (~50), laryngeal cancer (~2), chronic laryngitis/polyps (~50) = ~3,050 per 100k. Low confidence due to heterogeneous conditions and significant overlap.",weak,high,False,,,,
C0023269,Leiomyosarcoma,0.4,,incidence,32000,0.7,True,Soft Tissue Sarcoma,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Global STS incidence ~4 per 100k; leiomyosarcoma ~0.4 per 100k. Second most common adult STS.,moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0023418,leukemia,9.5,,incidence,760000,0.88,False,,"Reporting incidence (new diagnoses). All leukemias combined (ALL, AML, CLL, CML) incidence ~9.5 per 100k globally from GLOBOCAN 2002 data.",strong,moderate,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0023434,Chronic Lymphocytic Leukemia,4.2,,incidence,336000,0.88,True,Leukemia,CLL incidence ~4.2 per 100k person-years from cancer registry data (GLOBOCAN 2005/SEER). More common in males (2:1 ratio) and Caucasians. Median age at diagnosis 70 years.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023449,Acute lymphocytic leukemia,1.7,,incidence,136000,0.85,True,Acute Leukemia,ALL global incidence ~1.7 per 100k person-years from cancer registries. Bimodal distribution: peak in children age 2-5 (~3-4 per 100k) and smaller peak in elderly. More common in developed countries. GLOBOCAN 2005 data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023452,Childhood Acute Lymphoblastic Leukemia,0.9,,incidence,72000,0.82,True,Acute Lymphoblastic Leukemia,"Pediatric ALL (age 0-19) incidence ~3.5-4 per 100k children. Expressed per 100k total population (children ~25% globally), approximately 0.9 per 100k. Strong pediatric cancer registry data from SEER and international registries circa 2005.",strong,low,False,2005,"Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0023465,Acute monocytic leukemia,0.6,,incidence,48000,0.72,True,Acute Myeloid Leukemia,"Acute monocytic leukemia (AML M5 subtype) represents approximately 15-20% of AML cases. Global AML incidence ~3.5 per 100k, thus M5 subtype ~0.6 per 100k.",moderate,moderate,False,,GLOBOCAN cancer registry data and WHO classification of AML subtypes,https://gco.iarc.fr/,registry
C0023467,"Leukemia, Myelocytic, Acute",3.5,,incidence,280000,0.88,True,Leukemia,Acute myeloid leukemia (AML) incidence ~3.5 per 100k globally from GLOBOCAN 2005 cancer registry data. Well-documented cancer with strong epidemiological surveillance.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023470,Myeloid Leukemia,4.7,,incidence,376000,0.6,False,,Aggregate estimate combining AML (~3.7 per 100k) and CML (~1.0 per 100k) from cancer registry data. Total ~4.7 per 100k. Moderate confidence as this is a sum of two well-defined subtypes.,moderate,moderate,False,2005,GLOBOCAN 2005 (IARC) - combined AML and CML estimates,https://gco.iarc.fr/,registry
C0023473,"Myeloid Leukemia, Chronic",1.5,,incidence,120000,0.88,True,Myeloid Leukemia,Chronic Myeloid Leukemia (CML) incidence ~1-2 per 100k from cancer registries. Well-documented cancer with consistent global rates.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0023479,Acute myelomonocytic leukemia,0.6,,incidence,48000,0.55,True,Acute Myeloid Leukemia,"AML FAB M4 subtype comprises ~15-20% of AML cases. Global AML incidence ~3-4 per 100k, yielding M4 incidence ~0.6 per 100k. Limited subtype-specific registry data.",moderate,low,False,,Dohner H et al. (2010). Diagnosis and management of acute myeloid leukemia in adults. Blood. 115(3):453-474,https://pubmed.ncbi.nlm.nih.gov/19880497/,literature
C0023484,"Leukemia, Plasma Cell",extremely rare,,incidence,extremely rare,0.45,True,Plasma Cell Neoplasms,"Plasma cell leukemia is an aggressive variant of multiple myeloma, representing <2% of plasma cell malignancies. Estimated at <0.02 per 100k based on multiple myeloma incidence (~4 per 100k) and PCL proportion.",weak,low,False,,,,
C0023487,Acute Promyelocytic Leukemia,0.5,,incidence,40000,0.85,True,Acute Myeloid Leukemia,"APL represents 10-15% of AML cases. Global AML incidence ~4 per 100k, therefore APL ~0.5 per 100k. Well-documented in cancer registries with characteristic t(15;17) translocation.",strong,low,False,2005,"SEER Cancer Statistics Review, NCI",https://seer.cancer.gov/,registry
C0023492,"Leukemia, T-Cell",0.8,,incidence,64000,0.68,True,Leukemia,"T-cell leukemias comprise ~15-20% of acute lymphoblastic leukemias and include ATLL, T-PLL, and other subtypes. Estimated ~0.8 per 100k globally based on leukemia registry data.",moderate,moderate,False,,SEER Cancer Statistics Review 1975-2005,https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0023493,Adult T-Cell Lymphoma/Leukemia,0.3,,incidence,24000,0.72,True,T-Cell Leukemia,"ATLL caused by HTLV-1 infection. Global incidence ~0.3 per 100k but highly variable: <0.01 in non-endemic areas, 3-5 per 100k in endemic regions (southwestern Japan, Caribbean). Using global weighted average.",strong,high,False,2005,Proietti FA et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68,https://pubmed.ncbi.nlm.nih.gov/16155612/,literature
C0023524,"Leukoencephalopathy, Progressive Multifocal",extremely rare,,incidence,extremely rare,0.45,False,,"PML is extremely rare in general population (<0.1 per 100k), occurring primarily in immunocompromised patients. In HIV+ populations circa 2005, incidence ~0.5-1 per 100k HIV+ persons.",moderate,moderate,False,2005,"Engsig FN et al. (2009). Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era. J Infect Dis. 199(1):77-83",https://pubmed.ncbi.nlm.nih.gov/19007313/,literature
C0023794,Lipoidosis,1.5,,incidence,120000,0.45,False,,"Umbrella term for lipid storage diseases (Gaucher, Niemann-Pick, Fabry, etc.). Aggregate estimate of major lipidoses: ~1.5 per 100k births. Moderate confidence due to heterogeneous conditions and incomplete registries.",moderate,moderate,False,,,,estimate
C0023827,Liposarcoma,0.25,,incidence,20000,0.72,True,Soft Tissue Sarcoma,Liposarcoma represents ~20% of soft tissue sarcomas. Global STS incidence ~3-5 per 100k; liposarcoma ~0.25 per 100k (most common adult STS subtype).,moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0023890,Liver Cirrhosis,25.0,,incidence,2000000,0.65,False,,"Liver cirrhosis incidence estimated at ~25 per 100k person-years globally based on WHO mortality data and epidemiological studies. Data quality is moderate as cirrhosis often develops over years and incidence measurement varies. Geographic variation is high due to differences in alcohol consumption, hepatitis B/C prevalence, and NAFLD rates.",moderate,high,False,,Blachier M et al. (2013). The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 58(3):593-608,https://pubmed.ncbi.nlm.nih.gov/23419824/,literature
C0023896,Alcoholic Liver Diseases,25.0,,incidence,2000000,0.55,False,,"Umbrella term covering alcoholic fatty liver, hepatitis, and cirrhosis. Aggregate estimate ~25 per 100k for clinically significant alcoholic liver disease. Confidence limited by heterogeneity and regional variation in alcohol consumption.",moderate,high,False,,,,
C0023903,Liver neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous: includes benign tumors (hemangiomas, adenomas with incidence <5) and malignant tumors (HCC ~12, cholangiocarcinoma ~2, metastatic disease varying widely). Vastly different clinical significance and epidemiology. Aggregate not meaningful.",none,high,False,,,,
C0024115,Lung diseases,,,,,0.0,False,,"Umbrella term too heterogeneous and broad: encompasses acute infections (pneumonia, TB), chronic conditions (COPD, asthma), cancers (lung cancer), and structural diseases. Mix of incidence-based and prevalence-based conditions with different etiologies makes aggregate estimate meaningless.",none,unknown,False,,,,
C0024121,Lung Neoplasms,35.0,,incidence,2800000,0.72,False,,"Reporting incidence of lung neoplasms, predominantly malignant (lung cancer). GLOBOCAN 2005 shows lung cancer at ~35 per 100k globally. Confidence reduced slightly as 'neoplasms' technically includes rare benign tumors, but malignant cases dominate (>95%).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0024131,Lupus Vulgaris,0.15,,incidence,12000,0.45,True,Cutaneous Tuberculosis,"Lupus vulgaris is the most common form of cutaneous TB in endemic areas but very rare overall. Estimated <0.2 per 100k in most regions, higher in TB-endemic areas. Limited systematic epidemiological data.",weak,high,False,,,,
C0024138,"Lupus Erythematosus, Discoid",4.0,,incidence,320000,0.65,True,Lupus Erythematosus,"Discoid lupus erythematosus (DLE) incidence ~4 per 100k person-years, may be slightly more common than SLE. Limited population-based registry data; estimates based on dermatology cohort studies.",moderate,moderate,False,,Gronhagen CM et al. (2011). Incidence of cutaneous lupus erythematosus in Sweden. Br J Dermatol. 165(3):591-596,https://pubmed.ncbi.nlm.nih.gov/21574970/,literature
C0024141,"Lupus Erythematosus, Systemic",5.0,,incidence,400000,0.82,False,,"SLE incidence ~5 per 100k person-years based on population-based registries. Strong epidemiological data from multiple cohorts, though significant ethnic and geographic variation (higher in African, Asian, Hispanic populations).",strong,high,False,,Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,https://pubmed.ncbi.nlm.nih.gov/19136143/,literature
C0024232,Lymphatic Metastasis,,,,,0.0,False,,"Lymphatic metastasis is a manifestation of primary cancers, not a primary disease entity itself. Incidence depends entirely on the primary cancer type and stage. Unmappable without specification of primary malignancy.",none,unknown,False,,,,
C0024299,Lymphoma,15.5,,incidence,1240000,0.25,False,,Aggregate BOTEC estimate summing major lymphoma subtypes: Non-Hodgkin lymphoma (~12-13 per 100k) + Hodgkin lymphoma (~2.5 per 100k) = ~15.5 per 100k globally. Umbrella term with significant heterogeneity between subtypes.,weak,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0024301,"Lymphoma, Follicular",2.8,,incidence,224000,0.78,True,Non-Hodgkin Lymphoma,"Follicular lymphoma incidence approximately 2.8 per 100k person-years globally, comprising about 20-30% of non-Hodgkin lymphomas. Data from SEER and international cancer registries circa 2000-2005.",strong,moderate,False,2005,"Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",https://pubmed.ncbi.nlm.nih.gov/16150940/,literature
C0024305,"Lymphoma, Non-Hodgkin",5.3,,incidence,424000,0.85,False,,Reporting incidence of new diagnoses. Non-Hodgkin lymphoma encompasses multiple subtypes with global incidence of approximately 5.3 per 100k population. Incidence increases with age. Data from GLOBOCAN 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0024314,Lymphoproliferative Disorders,25,,incidence,2000000,0.28,False,,"Aggregate BOTEC estimate summing major lymphoproliferative conditions: NHL (~12 per 100k), Hodgkin lymphoma (~2.5), CLL (~4.5), Multiple myeloma (~4), Other (~2). Total ~25 per 100k. Low confidence due to heterogeneity and composite nature.",weak,moderate,False,,,,estimate
C0024534,"Malaria, Cerebral",2.5,,incidence,200000,0.65,True,Severe Malaria,"Cerebral malaria is a severe complication of P. falciparum malaria. Global incidence estimated at 2-3 per 100k averaged across all populations, but varies dramatically by region (0.01 in non-endemic areas to >10 per 100k in high-transmission zones). Based on WHO 2005 malaria data extrapolated to cerebral complications.",moderate,high,False,2005,WHO World Malaria Report 2005,https://www.who.int/publications/i/item/9241593199,registry
C0024623,Malignant neoplasm of stomach,22.0,,incidence,1760000,0.88,True,Gastrointestinal Neoplasms,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 data shows gastric cancer incidence ~22 per 100k globally, with high geographic variation (high in East Asia, lower in Western countries).",strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0024713,Manic Disorder,15,800,both,1200000,0.68,True,Bipolar Disorder,"Manic disorder (bipolar disorder with manic episodes) has similar epidemiology to bipolar depression. Incidence ~15 per 100k person-years, lifetime prevalence ~0.8%. Moderate confidence from population-based psychiatric surveys.",moderate,low,False,2004,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0025149,Medulloblastoma,0.6,,incidence,48000,0.75,True,Central Nervous System Tumor,Reporting incidence of new cases. Medulloblastoma global incidence ~0.6 per 100k all ages (higher in children at ~6 per 100k pediatric population). Most common malignant pediatric brain tumor from CBTRUS data.,strong,low,False,2004,"CBTRUS Statistical Report 2004-2005, Central Brain Tumor Registry of the United States",https://www.cbtrus.org/,registry
C0025202,melanoma,2.8,,incidence,224000,0.85,False,,"Reporting incidence (new cancer diagnoses). GLOBOCAN 2002 global melanoma incidence ~2.8 per 100k, highly variable by region (>10 per 100k in Australia/NZ, <0.5 in Asia).",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0025362,Mental Retardation,,1500,prevalence,120000000,0.65,False,,Outdated term for intellectual disability. Prevalence-based metric appropriate for this developmental/lifelong condition. Global prevalence ~1-2% (1500 per 100k) based on WHO estimates. Moderate confidence due to acceptable prevalence data but no specific 2005 source and variation in diagnostic criteria.,moderate,moderate,False,,WHO estimates on developmental disabilities,,estimate
C0026205,Miosis disorder,,,,,0.0,False,,"Miosis is a clinical sign (pupillary constriction) rather than a disease entity. Can result from multiple causes (opioids, neurological conditions, eye disorders). Not tracked epidemiologically as an independent condition.",none,unknown,False,,,,
C0026277,Mixed Salivary Gland Tumor,1.0,,incidence,80000,0.65,True,Salivary Gland Neoplasm,"Pleomorphic adenoma (mixed tumor) is the most common salivary gland tumor, comprising approximately 60-70% of all salivary gland neoplasms. With total salivary gland tumor incidence of 1-2 per 100k, mixed tumor incidence is approximately 1 per 100k.",moderate,low,False,,"Speight PM, Barrett AW (2002). Salivary gland tumours. Oral Dis. 8(5):229-240",https://pubmed.ncbi.nlm.nih.gov/12363107/,literature
C0026691,Mucocutaneous Lymph Node Syndrome,8.5,,incidence,680000,0.75,False,,"Kawasaki disease incidence varies dramatically by geography (Japan ~250/100k children, Western countries ~10-20/100k). Global weighted average ~8.5 per 100k all-age population based on pediatric incidence data from 2000s.",strong,high,False,2004,Nakamura Y et al. (2008). Epidemiologic features of Kawasaki disease in Japan. Pediatrics. 122(6):e1167-72,https://pubmed.ncbi.nlm.nih.gov/19047216/,literature
C0026764,Multiple Myeloma,4.5,,incidence,360000,0.85,True,Plasma Cell Neoplasms,Reporting incidence of new multiple myeloma diagnoses. GLOBOCAN 2005 estimates approximately 4.5 per 100k person-years globally. Well-defined hematological malignancy with reliable registry data. Higher incidence in developed countries and older populations.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0026848,Myopathy,,,,,0.0,False,,"Umbrella term covering numerous distinct muscle diseases (inflammatory, metabolic, toxic, genetic, congenital, endocrine myopathies) with vastly different incidence rates and etiologies. Too heterogeneous to estimate meaningfully without disease-specific specification.",none,unknown,False,,,,
C0026896,Myasthenia Gravis,1.0,,incidence,80000,0.75,False,,Autoimmune neuromuscular disorder with incidence ~1.0 per 100k person-years globally. Based on population-based epidemiological studies showing 0.5-2.0 per 100k depending on region.,strong,moderate,False,,Phillips LH 2nd et al. (2004). The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 998:407-412,https://pubmed.ncbi.nlm.nih.gov/15067620/,literature
C0026948,Mycosis Fungoides,0.4,,incidence,32000,0.65,True,Cutaneous T-cell Lymphoma,"Rare cutaneous T-cell lymphoma with global incidence ~0.4 per 100k person-years. Data from cancer registries, though rare cancers have less robust surveillance.",moderate,moderate,False,,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(12):1421-7,https://pubmed.ncbi.nlm.nih.gov/20026852/,literature
C0026987,Myelofibrosis,0.8,,incidence,64000,0.7,False,,"Reporting incidence of myelofibrosis (including primary and secondary). Global incidence ~0.5-1.5 per 100k person-years, using midpoint estimate of 0.8.",moderate,low,False,2005,"Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",https://pubmed.ncbi.nlm.nih.gov/18616696/,literature
C0027013,Myeloid Metaplasia,0.8,,incidence,64000,0.65,False,,"Reporting incidence. Myeloid metaplasia is an older term essentially synonymous with myelofibrosis, referring to extramedullary hematopoiesis. Using same estimate as myelofibrosis (~0.8 per 100k), though this term is less commonly used in modern literature.",moderate,low,False,,"Rollison DE et al. (2008). Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004. Br J Haematol. 142(3):395-404",https://pubmed.ncbi.nlm.nih.gov/18616696/,literature
C0027022,Myeloproliferative Disease,5.5,,incidence,440000,0.25,False,,"Aggregate BOTEC estimate summing major myeloproliferative neoplasms: polycythemia vera (~1.5), essential thrombocythemia (~1.5), primary myelofibrosis (~0.5), chronic myeloid leukemia (~1-2). Total ~5.5 per 100k. Low confidence due to umbrella term heterogeneity.",weak,moderate,False,,,,estimate
C0027051,Myocardial Infarction,220,,incidence,17600000,0.82,True,Ischemic Heart Disease,"Acute MI incidence ~220 per 100k globally from WHO cardiovascular disease surveillance circa 2005, with high geographic variation (higher in developed nations).",strong,high,True,2005,WHO Global Burden of Disease 2005 Study,https://www.who.int/healthinfo/global_burden_disease/,registry
C0027612,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities",,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses thousands of distinct conditions across all organ systems including genetic syndromes, congenital malformations, metabolic disorders, and neonatal infections with vastly different incidence rates.",none,unknown,False,,,,
C0027627,Neoplasm Metastasis,,,,,0.0,False,,"Unmappable: Metastasis is a process/complication of cancer, not a primary disease entity. Incidence depends entirely on the primary cancer type, staging, and treatment. Cannot provide meaningful aggregate estimate.",none,unknown,False,,,,
C0027651,Neoplasms,,,,,0.0,False,,Umbrella term too broad and generic to estimate meaningfully. Encompasses all benign and malignant tumors across all organ systems with vastly different incidence rates and clinical significance.,none,unknown,False,,,,
C0027765,nervous system disorder,,,,,0.0,False,,"Unmappable umbrella term encompassing all neurological conditions (stroke, epilepsy, Parkinson's, MS, migraines, neuropathy, etc.). Too heterogeneous and broad to provide meaningful aggregate estimate.",none,unknown,False,,,,
C0027819,Neuroblastoma,0.9,,incidence,72000,0.87,False,,Neuroblastoma primarily affects children (90% diagnosed before age 5). Overall population incidence ~0.9 per 100k. Data from SEER and international cancer registries.,strong,low,True,2005,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0027831,Neurofibromatosis 1,0.67,,incidence,53600,0.72,True,Neurofibromatosis,"Reporting incidence based on birth prevalence of 1 in 3,000 live births. With global birth rate ~2,000 per 100k per year (2005), population incidence is ~0.67 per 100k person-years. Well-documented genetic disorder.",strong,low,False,,Lammert M et al. (2005). Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 141(1):71-74,https://pubmed.ncbi.nlm.nih.gov/15655144/,literature
C0028754,Obesity,,9800,prevalence,784000000,0.82,False,,"Obesity measured as prevalence, not incidence. WHO 2005 data shows 9.8% of global adults obese (9,800 per 100k).",strong,high,True,2005,Kelly T et al. (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes. 32:1431-1437,https://pubmed.ncbi.nlm.nih.gov/18607383/,literature
C0029182,orbit (eye disorders),,,,,0.0,False,,"Umbrella term covering all orbital disorders including orbital tumors, thyroid eye disease, orbital infections, trauma, congenital abnormalities, and inflammatory conditions. Too heterogeneous to estimate meaningfully without specification of specific orbital condition.",none,unknown,False,,,,
C0029408,Degenerative polyarthritis,240,,incidence,19200000,0.65,True,Osteoarthritis,Degenerative polyarthritis refers to osteoarthritis affecting multiple joints. Symptomatic OA incidence ~240 per 100k based on primary care and registry data (2000-2010). Lower confidence due to variable diagnostic criteria and reporting of polyarticular vs monoarticular disease.,moderate,moderate,False,2005,"Oliveria SA et al. (1995). Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 38(8):1134-41",https://pubmed.ncbi.nlm.nih.gov/7639811/,literature
C0029422,Osteochondrodysplasias,2.5,,incidence,200000,0.22,False,,"Aggregate BOTEC estimate summing major skeletal dysplasias: achondroplasia (~0.4 per 100k births), osteogenesis imperfecta (~0.5), multiple epiphyseal dysplasia (~0.3), other rare types (~1.3) = ~2.5 per 100k births. Highly heterogeneous group of >400 genetic conditions.",weak,low,False,,,,
C0029463,Osteosarcoma,0.35,,incidence,28000,0.75,False,,Reporting incidence at ~0.35 per 100k person-years. Most common primary bone malignancy with incidence of 3-4 per million globally based on SEER and international cancer registry data including GLOBOCAN.,strong,low,False,,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0029925,Ovarian Carcinoma,6.3,,incidence,504000,0.88,False,,Ovarian cancer global incidence from GLOBOCAN 2005: ~6.3 per 100k women (age-standardized rate). Well-documented cancer with strong registry data from multiple countries.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0030297,Pancreatic Neoplasm,7.5,,incidence,600000,0.65,False,,Umbrella term covering benign and malignant pancreatic tumors. Reporting primarily malignant pancreatic cancer incidence at ~7.5 per 100k from GLOBOCAN 2005 data. Benign neoplasms are less well documented. Confidence reduced due to heterogeneity of term.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0030319,Panic Disorder,280,2700,both,22400000,0.72,True,Anxiety Disorders,Reporting incidence of ~280 per 100k person-years for new onset panic disorder. Lifetime prevalence ~2.7% (2700 per 100k) based on epidemiological surveys from early 2000s.,strong,moderate,False,2005,"Kessler RC et al. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 63(4):415-424",https://pubmed.ncbi.nlm.nih.gov/16585471/,literature
C0030354,Papilloma,,,,,0.0,False,,"Umbrella term covering 25+ distinct papilloma types (breast, bladder, laryngeal, skin, etc.) with vastly different incidence rates ranging from <1 to >100 per 100k. Cannot meaningfully aggregate.",none,high,False,,,,
C0030552,Paresis,,,,,0.0,False,,"Symptom descriptor (partial weakness/paralysis) rather than disease entity. Can result from stroke, spinal cord injury, MS, neuropathies, brain lesions, etc. Too broad and non-specific to assign disease incidence without underlying cause specification.",none,unknown,False,,,,
C0030567,Parkinson Disease,13.4,,incidence,1072000,0.78,False,,"Parkinson disease incidence ~13.4 per 100k person-years globally (age-adjusted). Incidence increases dramatically with age: <1 per 100k under age 50, rising to >100 per 100k over age 80. Based on systematic review data circa 2005.",strong,moderate,False,2005,de Lau LM et al. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5(6):525-535,https://pubmed.ncbi.nlm.nih.gov/16713924/,literature
C0031069,Familial Mediterranean Fever,2.0,,incidence,160000,0.65,False,,"Reporting incidence of new diagnoses. Global average ~2 per 100k, but varies dramatically from <0.1 in Northern Europe to 100-200 per 100k in high-risk Mediterranean populations (Sephardic Jews, Armenians, Turks).",moderate,high,False,,Ozen S et al. (2009). Familial Mediterranean fever. Nat Rev Rheumatol. 5:10-16,https://pubmed.ncbi.nlm.nih.gov/19098926/,literature
C0031090,Periodontal Diseases,,50000,prevalence,4000000000,0.72,False,,"Umbrella term for gingivitis, periodontitis, and related conditions. Reporting prevalence as chronic condition (~50% global adult prevalence for moderate-to-severe periodontal disease based on WHO Global Oral Health Data Bank circa 2005).",strong,moderate,False,2005,Petersen PE et al. (2005). The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 60(1):15-39,https://pubmed.ncbi.nlm.nih.gov/22909104/,literature
C0031094,Periodontal Pocket,,35000,prevalence,2800000000,0.55,True,Periodontal Diseases,Periodontal pockets are a clinical manifestation of periodontitis rather than a distinct disease. Reporting prevalence (~35% of adults globally have periodontal pockets ≥4mm based on NHANES and global surveys). Confidence moderate due to being a clinical finding rather than disease entity.,moderate,moderate,False,,Eke PI et al. (2012). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 91(10):914-920,https://pubmed.ncbi.nlm.nih.gov/22935673/,literature
C0032002,Pituitary Diseases,5.0,,incidence,400000,0.25,False,,"Aggregate BOTEC estimate summing major pituitary conditions: pituitary adenomas (~4 per 100k), hypopituitarism (~0.5), acromegaly (~0.3), other rare conditions (~0.2) = ~5 per 100k. Heterogeneous group with varying pathophysiology.",weak,moderate,False,,,,
C0032285,Pneumonia,1200,,incidence,96000000,0.78,False,,Community-acquired pneumonia incidence approximately 1200 per 100k person-years globally based on WHO estimates circa 2005. Varies significantly by age (higher in children <5 and adults >65) and region.,strong,high,False,2004,Rudan I et al. (2008). Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 86(5):408-416,https://pubmed.ncbi.nlm.nih.gov/18545744/,literature
C0032580,Adenomatous Polyposis Coli,1.2,,incidence,96000,0.75,True,Polyposis Syndrome,"Familial Adenomatous Polyposis (FAP) incidence ~1 in 8,000-10,000 births (1.2 per 100k). Well-documented genetic condition with clear diagnostic criteria.",strong,low,False,,Jasperson KW et al. (2010). Hereditary and familial colon cancer. Gastroenterology. 138(6):2044-2058,https://pubmed.ncbi.nlm.nih.gov/20420945/,literature
C0032927,Precancerous Conditions,,,,,0.0,False,,"Umbrella term covering heterogeneous conditions across multiple organs (cervical dysplasia, colorectal polyps, Barrett's esophagus, DCIS, etc.) with vastly different detection rates and clinical significance. Too broad to estimate meaningfully.",none,unknown,False,,,,
C0033578,Prostatic Neoplasms,25.3,,incidence,680000,0.88,False,,"Prostate cancer incidence from GLOBOCAN 2005: approximately 679,000 new cases globally in 2002, translating to ~25 per 100k men (age-standardized rate ~30 per 100k).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0033770,Prune Belly Syndrome,extremely rare,,incidence,extremely rare,0.42,False,,"Rare congenital condition (absent abdominal muscles, urinary tract abnormalities). Incidence ~3 per 100,000 live births based on birth defect registries. Predominantly affects males (95%).",moderate,low,False,,Routh JC et al. (2010). Epidemiological trends in pediatric urologic practice: the prune belly syndrome experience. J Urol. 184(4):1702-6,https://pubmed.ncbi.nlm.nih.gov/20728144/,literature
C0033999,Pterygium,8.0,,incidence,640000,0.52,False,,Pterygium (fibrovascular conjunctival growth onto cornea) incidence ~8 per 100k globally. Strongly UV-dependent with 10-fold+ variation by latitude. Limited systematic incidence studies; estimate based on prevalence data and typical progression rates.,moderate,high,False,,,,
C0034067,Pulmonary Emphysema,,1800,prevalence,144000000,0.72,True,Chronic Obstructive Pulmonary Disease (COPD),"Emphysema is a chronic structural lung disease (part of COPD spectrum) measured by prevalence. Global COPD prevalence ~10% of adults over 40, emphysema comprises roughly 40-50% of COPD cases. Estimated ~1800 per 100k total population.",moderate,high,False,2007,Halbert RJ et al. (2006). Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 28(3):523-532,https://pubmed.ncbi.nlm.nih.gov/16611654/,literature
C0035334,Retinitis Pigmentosa,1.2,25,both,96000,0.75,False,,Inherited retinal dystrophy with prevalence ~1 in 4000 (25 per 100k) and incidence ~1-1.5 per 100k births. Both metrics documented. Prevalence more commonly cited for this progressive genetic condition.,strong,low,False,2006,Hamel C. (2006). Retinitis pigmentosa. Orphanet J Rare Dis. 1:40,https://pubmed.ncbi.nlm.nih.gov/17032466/,literature
C0035335,Retinoblastoma,0.4,,incidence,32000,0.78,False,Eye Neoplasms,Reporting incidence (new diagnoses). Rare pediatric eye cancer with global incidence ~3-4 per million children or ~0.4 per 100k total population. Data from cancer registries and IARC.,strong,moderate,False,2005,"Kivela T (1999). The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 83(7):767-73",https://pubmed.ncbi.nlm.nih.gov/10381661/,literature
C0035372,Rett Syndrome,5.0,,incidence,40000,0.75,False,,"Rett syndrome incidence ~1 per 10,000-15,000 female births, approximately 5 per 100k total births. Well-documented X-linked dominant disorder caused by MECP2 mutations.",strong,low,False,2005,Laurvick CL et al. (2006). Rett syndrome in Australia: a review of the epidemiology. J Pediatr. 148(3):347-352,https://pubmed.ncbi.nlm.nih.gov/16615965/,literature
C0036220,Kaposi Sarcoma,2.5,,incidence,200000,0.75,False,,"KS incidence strongly linked to HIV/AIDS prevalence. Global incidence ~2.5 per 100k in 2005, with dramatic variation: <0.1 in developed countries, >20 per 100k in sub-Saharan Africa during peak HIV epidemic.",strong,high,True,2005,"Parkin DM et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0036341,Schizophrenia,15.2,400,both,1216000,0.82,False,,Well-defined psychiatric disorder with robust epidemiological data. Incidence approximately 15.2 per 100k person-years globally; lifetime prevalence approximately 0.4% (400 per 100k). Both metrics commonly reported; incidence shows peak onset in early adulthood.,strong,low,False,2005,"McGrath J et al. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30:67-76",https://pubmed.ncbi.nlm.nih.gov/18480098/,literature
C0036346,"Schizophrenia, Childhood",0.04,,incidence,3200,0.55,True,Schizophrenia,Childhood-onset schizophrenia (onset before age 13) is extremely rare: ~0.04 per 100k children per year based on pediatric psychiatric literature. Much rarer than adult-onset schizophrenia.,moderate,low,False,,"Remschmidt H et al. (2007). Schizophrenia in children and adolescents. Cambridge University Press, citing epidemiological studies",,literature
C0036631,Seminoma,2.5,,incidence,200000,0.78,True,Testicular Germ Cell Tumors,"Reporting incidence (new diagnoses). Seminoma accounts for ~50% of testicular cancer cases. With testicular cancer incidence at ~5-6 per 100k men globally (~2.5-3 per 100k total population), seminoma is ~2.5 per 100k.",strong,moderate,False,2005,McGlynn KA et al. (2005). Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 97(1):63-70,https://pubmed.ncbi.nlm.nih.gov/12491506/,literature
C0036646,Age-related cataract,,8500,prevalence,680000000,0.68,True,Cataract,"Age-related cataract measured as prevalence (chronic condition). WHO 2004-2005 data indicates cataract affects ~8-9% of global population over age 40, representing the largest cause of blindness globally. Prevalence more appropriate than incidence for this progressive condition.",strong,moderate,False,2004,"Pascolini D, Mariotti SP. (2012). Global estimates of visual impairment: 2010. Br J Ophthalmol. 96(5):614-618",https://pubmed.ncbi.nlm.nih.gov/22133988/,literature
C0036690,Septicemia,75,,incidence,6000000,0.62,True,Sepsis,Septicemia (bloodstream infection) is a specific subtype of sepsis. Incidence estimated ~75 per 100k based on blood culture-confirmed bacteremia rates from hospital registries.,moderate,high,False,,,,
C0036920,Sezary Syndrome,extremely rare,,incidence,extremely rare,0.35,True,Cutaneous T-Cell Lymphoma,Rare leukemic variant of cutaneous T-cell lymphoma. Estimated <0.1 per 100k based on SEER and registry data. Represents ~5% of CTCL cases.,weak,unknown,False,,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(8):870-6,https://pubmed.ncbi.nlm.nih.gov/19687417/,literature
C0037579,Soft Tissue Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous: includes benign soft tissue tumors (lipomas, hemangiomas - extremely common) and malignant sarcomas (rare, ~5 per 100k). Vastly different clinical significance and epidemiology make aggregate estimate meaningless.",none,high,False,,,,
C0038354,Stomach Diseases,,,,,0.0,False,,"Umbrella term covering vastly different conditions (gastritis, peptic ulcers, gastric cancer, gastroparesis, etc.) with different incidence rates, severities, and clinical significance. Too heterogeneous to estimate meaningfully.",none,high,False,,,,
C0038356,Stomach Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully: includes gastric adenocarcinoma (most common, ~10-15 per 100k), gastric lymphoma (<1 per 100k), GISTs (~1-2 per 100k), benign polyps, and other rare tumors with vastly different incidence rates and clinical significance.",none,high,False,,,,
C0038436,Post-Traumatic Stress Disorder,,350,prevalence,28000000,0.65,False,,PTSD primarily measured as prevalence (~3.5% or 350 per 100k adults). Incidence poorly documented as onset varies widely after trauma exposure. Using prevalence data from epidemiological studies.,moderate,high,False,2005,Kessler RC et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders. Arch Gen Psychiatry. 62(6):593-602,https://pubmed.ncbi.nlm.nih.gov/15939837/,literature
C0038454,Cerebrovascular accident,200.0,,incidence,16000000,0.85,False,,"Reporting incidence (new strokes per year). WHO STEPS Stroke 2005 data shows global stroke incidence ~200 per 100k person-years, with significant geographic variation.",strong,high,True,2005,Strong K et al. (2007). Preventing stroke: saving lives around the world. Lancet Neurol. 6(2):182-187,https://pubmed.ncbi.nlm.nih.gov/17239805/,literature
C0038644,Sudden infant death syndrome,7.5,,incidence,6000,0.75,False,,"SIDS incidence ~0.55 per 1000 live births globally in 2005 (post Back-to-Sleep era). With ~133M births/year globally, approximately 73,000 SIDS deaths/year. Reported per 100k infants (0-1 year population ~133M, or ~1.7% of 8B = 136M) = ~54 per 100k infants. Converted to general population incidence: ~7.5 per 100k person-years. High geographic variation (0.2-0.8 per 1000 births).",strong,high,True,2005,Hauck FR et al. (2008). International trends in sudden infant death syndrome: stabilization of rates requires further action. Pediatrics. 122(3):660-666,https://pubmed.ncbi.nlm.nih.gov/18762537/,literature
C0039483,Giant Cell Arteritis,10.0,,incidence,800000,0.82,True,Vasculitis,"GCA incidence varies by age and geography. Population-adjusted global average ~10 per 100k, with peak incidence 15-25 per 100k in populations >50 years. Strong registry data from Northern Europe and North America.",strong,high,False,2004,Salvarani C et al. (2004). Epidemiology of giant cell arteritis. Clin Exp Rheumatol. 22(6 Suppl 36):S23-7,https://pubmed.ncbi.nlm.nih.gov/15675131/,literature
C0039585,Androgen-Insensitivity Syndrome,,2.0,prevalence,160000,0.55,False,,"Genetic condition present from birth, so prevalence is more appropriate than incidence. Complete AIS prevalence ~1-2 per 100k; partial AIS may be slightly higher. Limited population-based studies; confidence moderate due to underdiagnosis.",moderate,low,False,,Hughes IA et al. (2006). Consensus statement on management of intersex disorders. Arch Dis Child. 91(7):554-563,https://pubmed.ncbi.nlm.nih.gov/16624884/,literature
C0039730,Thalassemia,,25,prevalence,2000000,0.65,False,,"Umbrella term for alpha and beta thalassemia. Reporting prevalence of symptomatic disease (thalassemia major/intermedia) at ~25 per 100k globally. Well-studied genetic hemoglobinopathy with established epidemiology, though incidence varies dramatically by region (much higher in Mediterranean, Southeast Asia, Middle East). Carrier prevalence is much higher (~1500-3000 per 100k).",moderate,high,False,,WHO guidelines on thalassemia and hemoglobinopathies,,literature
C0040136,Thyroid Neoplasm,,,,,0.0,False,,Umbrella term too heterogeneous: includes benign thyroid adenomas (prevalence ~5-10% of adults by autopsy/ultrasound) and malignant thyroid cancers (incidence ~10 per 100k). Vastly different clinical significance and epidemiological patterns. Not meaningful to aggregate.,none,high,False,,,,
C0041696,Unipolar Depression,370,3300,both,29600000,0.75,True,Depressive Disorders,"Unipolar depression (major depression without bipolar features) has global incidence ~370 per 100k person-years for new episodes, with prevalence ~3.3% (3300 per 100k). WHO 2004-2005 GBD data.",strong,moderate,True,2004,WHO Global Burden of Disease Study 2004,https://www.who.int/healthinfo/global_burden_disease/,registry
C0042373,Vascular Diseases,,,,,0.0,False,,"Umbrella term far too broad to estimate meaningfully. Encompasses coronary artery disease, stroke, peripheral artery disease, aneurysms, vasculitis, venous thrombosis - each with distinct epidemiology and clinical significance. Aggregate estimate would not be useful.",none,high,False,,,,
C0042384,Vasculitis,40,,incidence,3200000,0.28,False,,"Aggregate BOTEC estimate summing major vasculitides: Giant cell arteritis (~10), Takayasu arteritis (~2), Polyarteritis nodosa (~2), Microscopic polyangiitis (~3), Granulomatosis with polyangiitis (~5), Eosinophilic granulomatosis (~2), Henoch-Schönlein purpura (~10), Behçet's (~3), other (~3) = ~40 per 100k. Heterogeneous group with overlap and variable diagnostic criteria.",weak,high,False,,,,estimate
C0042514,"Tachycardia, Ventricular",2.5,,incidence,200000,0.45,True,Cardiac Arrhythmias,Reporting incidence of sustained ventricular tachycardia at approximately 2-3 per 100k person-years in general population. Incidence varies significantly based on underlying heart disease prevalence. Limited population-based registry data available.,moderate,moderate,False,,,,
C0043119,Werner Syndrome,extremely rare,,incidence,extremely rare,0.45,False,Progeroid Syndrome,"Werner syndrome is an extremely rare autosomal recessive progeroid disorder. Prevalence estimated at 1-9 per million, translating to incidence <0.01 per 100k. Higher prevalence in Japan (~1 in 50,000) due to founder effect.",weak,high,False,,"Oshima J et al. (2017). Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev. 33:105-114",https://pubmed.ncbi.nlm.nih.gov/27374323/,literature
C0043346,Xeroderma Pigmentosum,extremely rare,,incidence,extremely rare,0.45,False,,"Extremely rare autosomal recessive disorder. Birth incidence ~0.4 per 100k in US/Europe (1 in 250,000), higher in Japan (1 in 40,000). Limited systematic epidemiological data.",weak,high,False,,"Kleijer WJ et al. (2008). Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair. 7(5):744-750",https://pubmed.ncbi.nlm.nih.gov/18329345/,literature
C0079218,"Fibromatosis, Aggressive",0.3,,incidence,24000,0.65,True,Fibromatosis,Desmoid tumors (aggressive fibromatosis) have documented incidence of 2-4 per million per year (0.2-0.4 per 100k). Using midpoint estimate of 0.3 per 100k based on population-based registry data.,moderate,low,False,,"Reitamo JJ et al. (1982). The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 77(6):665-673",https://pubmed.ncbi.nlm.nih.gov/7091046/,literature
C0079298,Epidermolysis Bullosa Simplex,0.3,,incidence,24000,0.65,True,Epidermolysis Bullosa,EBS is the most common form of epidermolysis bullosa with estimated incidence of ~0.3 per 100k births. Based on epidemiological studies and rare disease registries.,moderate,low,False,,Fine JD et al. (2008). The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 58(6):931-950,https://pubmed.ncbi.nlm.nih.gov/18374450/,literature
C0079588,"Ichthyosis, X-Linked",0.3,,incidence,24000,0.68,True,Ichthyosis,"X-linked ichthyosis affects approximately 1 in 2,000-6,000 males (birth prevalence). Converting to incidence per 100k person-years with global birth rate: ~0.3 per 100k. Moderate confidence based on established genetic prevalence data.",moderate,low,False,,Orphanet and genetic disease registries,,registry
C0079731,B-Cell Lymphomas,12.0,,incidence,960000,0.28,False,,"Aggregate BOTEC estimate summing major B-cell lymphoma subtypes: DLBCL (~4.2), follicular lymphoma (~2.5), marginal zone (~1.5), CLL (~3.0), other B-cell lymphomas (~0.8) = ~12 per 100k. Low confidence due to heterogeneity and potential overlap.",weak,moderate,True,2005,,,estimate
C0079740,High Grade Lymphoma (neoplasm),8.5,,incidence,680000,0.45,True,Lymphoma,"High-grade/aggressive lymphomas comprise ~60-65% of NHL cases. Estimated ~8.5 per 100k based on NHL incidence (~13 per 100k) × proportion high-grade. Includes DLBCL, Burkitt, other aggressive subtypes.",moderate,moderate,False,,,,estimate
C0079744,Diffuse Large B-Cell Lymphoma,4.2,,incidence,336000,0.82,True,Non-Hodgkin Lymphoma,DLBCL is the most common NHL subtype (~30-40% of NHL cases). Global NHL incidence 2005 ~10-12 per 100k; DLBCL accounts for ~4.2 per 100k based on GLOBOCAN and registry data.,strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0079772,T-Cell Lymphoma,1.5,,incidence,120000,0.72,True,Non-Hodgkin Lymphoma,"Reporting incidence. T-cell lymphomas comprise ~10-15% of Non-Hodgkin lymphomas. Global NHL incidence ~10 per 100k, T-cell subtypes ~1.5 per 100k based on SEER and international registry data.",strong,moderate,False,2005,Vose J et al. (2008). International peripheral T-cell and natural killer/T-cell lymphoma study. J Clin Oncol. 26(25):4124-4130,https://pubmed.ncbi.nlm.nih.gov/18626005/,literature
C0085078,Lysosomal Storage Diseases,1.5,,incidence,120000,0.28,False,,"Aggregate BOTEC summing 50+ rare genetic disorders including Gaucher (0.5), Fabry (0.2), Pompe (0.2), MPS disorders (0.3), others (0.3). Total ~1.5 per 100k. Low confidence due to heterogeneity of conditions.",weak,moderate,False,,,,estimate
C0085110,Severe Combined Immunodeficiency,1.7,,incidence,136000,0.75,False,,"Reporting incidence per 100k births. SCID incidence ~1 in 58,000 live births (~1.7 per 100k births) based on newborn screening data.",strong,low,False,2010,Kwan A et al. (2014). Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 312(7):729-738,https://pubmed.ncbi.nlm.nih.gov/25138334/,literature
C0085215,"Ovarian Failure, Premature",,1000,prevalence,80000000,0.75,False,,"Primary Ovarian Insufficiency (POI) is a chronic condition best measured by prevalence rather than incidence. Affects approximately 1% of women under 40 (1,000 per 100k women). Data from epidemiological studies, though not 2005-specific.",moderate,moderate,False,,Coulam CB et al. (1986). Incidence of premature ovarian failure. Obstet Gynecol. 67(4):604-606,https://pubmed.ncbi.nlm.nih.gov/3960433/,literature
C0085576,Iron-Refractory Iron Deficiency Anemia,extremely rare,,incidence,extremely rare,0.35,True,Iron Deficiency Anemia,Reporting incidence of this rare genetic disorder caused by TMPRSS6 mutations. Extremely rare condition with <0.01 per 100k births based on case report literature. Limited systematic epidemiological data available.,weak,unknown,False,,De Falco L et al. (2013). Iron refractory iron deficiency anemia. Haematologica. 98(6):845-853,https://pubmed.ncbi.nlm.nih.gov/23729726/,literature
C0085669,Acute leukemia,5.5,,incidence,440000,0.8,False,Leukemia,Combined acute lymphoblastic leukemia (ALL ~1.8 per 100k) and acute myeloid leukemia (AML ~3.7 per 100k) from GLOBOCAN 2005 data. Total ~5.5 per 100k globally.,strong,moderate,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0085682,Hypophosphatemia,,2500,prevalence,200000000,0.55,False,,"Hypophosphatemia is a laboratory finding/metabolic state rather than a discrete disease. Reporting prevalence (~2-3% of general population, ~2500 per 100k) as incidence is poorly defined for this biochemical abnormality. Much higher in hospitalized patients (30-80%).",moderate,moderate,False,,,,
C0087012,"Ataxia, Spinocerebellar",0.8,3.0,both,64000,0.72,True,Cerebellar Ataxia,"Spinocerebellar ataxias (SCAs) are hereditary progressive ataxias with prevalence ~3 per 100k. Incidence of new clinical diagnoses ~0.8 per 100k person-years, accounting for typical age of onset (20-40 years) and disease progression.",strong,moderate,False,,Ruano L et al. (2014). The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 42(3):174-83,https://pubmed.ncbi.nlm.nih.gov/24603320/,literature
C0149678,Epstein-Barr Virus Infections,500,,incidence,40000000,0.65,False,,"Reporting incidence of symptomatic EBV infection (infectious mononucleosis). Global incidence ~500 per 100k person-years, highest in adolescents/young adults. Most infections are asymptomatic.",moderate,moderate,False,,Ebell MH. (2004). Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 70(7):1279-1287,https://pubmed.ncbi.nlm.nih.gov/15508538/,literature
C0149782,Squamous cell carcinoma of lung,5.5,,incidence,440000,0.82,True,Lung cancer,Squamous cell carcinoma comprises ~25-30% of lung cancers. Global lung cancer incidence ~20 per 100k (GLOBOCAN 2005); squamous cell subtype ~5.5 per 100k.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0149939,Obstructive nephropathy,4.5,,incidence,360000,0.45,False,,"Obstructive nephropathy encompasses various etiologies (stones, tumors, BPH, congenital). Estimated ~4-5 per 100k for acute presentations requiring intervention based on urology literature, but lacks systematic population-based tracking.",moderate,moderate,False,,,,
C0151650,Renal fibrosis,,,,,0.0,False,,"Renal fibrosis is a pathological process/endpoint rather than a distinct disease entity. It represents the common final pathway of various kidney diseases (CKD, diabetic nephropathy, glomerulonephritis). Cannot meaningfully assign independent incidence/prevalence as it's a histological feature, not a diagnostic category.",none,unknown,False,,,,
C0151744,Myocardial Ischemia,280,4500,both,22400000,0.72,False,,Broader term encompassing acute MI (~130 per 100k) and chronic ischemic heart disease (~150 per 100k). Total incidence ~280 per 100k based on WHO/MONICA data circa 2005. Geographic variation due to risk factors.,moderate,high,False,2005,WHO MONICA Project and Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0153676,Secondary malignant neoplasm of lung,25,,incidence,2000000,0.35,False,Metastatic Neoplasm,"Lung is the most common site for metastases from breast, colon, kidney, and other cancers. Estimated ~25 per 100k based on autopsy studies showing 30-55% of cancer patients develop lung metastases, but no systematic registry data. Low confidence due to heterogeneous primary sources and lack of population-based incidence studies.",weak,moderate,False,,,,
C0153690,Secondary malignant neoplasm of bone,85,,incidence,6800000,0.55,False,,"Bone metastases occur in ~70% of breast/prostate cancer patients and 30-40% of lung cancer patients. Estimating ~85 per 100k based on primary cancer incidence and metastasis rates, though incidence varies by primary cancer burden.",moderate,moderate,False,,Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s-6249s,https://pubmed.ncbi.nlm.nih.gov/17062708/,literature
C0158266,Intervertebral Disc Degeneration,,8500,prevalence,680000000,0.65,False,,"Chronic degenerative condition measured as prevalence. Symptomatic disc degeneration affects approximately 8.5% of adults globally based on population studies, though radiographic evidence is much higher. Using prevalence as incidence poorly defined for gradual degeneration.",moderate,moderate,False,,Hartvigsen J et al. (2018). What low back pain is and why we need to pay attention. Lancet. 391(10137):2356-2367,https://pubmed.ncbi.nlm.nih.gov/29573870/,literature
C0162429,Malnutrition,,15000,prevalence,1200000000,0.62,False,,"Malnutrition is better measured by prevalence than incidence. WHO 2005 data shows approximately 15% of global population (15,000 per 100k) affected by various forms of malnutrition including undernutrition and micronutrient deficiencies. Broad umbrella term with significant geographic variation.",moderate,high,True,2005,"WHO Global Database on Child Growth and Malnutrition, 2005",https://www.who.int/nutrition/databases/en/,registry
C0178874,Tumor Progression,,,,,0.0,False,,"Tumor progression is a pathological process describing how tumors advance and become more aggressive, not a disease entity. Cannot be assigned an incidence rate. This is a biological concept, not a diagnosis.",none,unknown,False,,,,
C0205698,Undifferentiated carcinoma,1.5,,incidence,120000,0.35,True,Carcinoma,"Undifferentiated carcinoma (poorly differentiated/anaplastic) occurs in various organs - thyroid, nasopharyngeal, bladder, etc. Estimated ~1.5 per 100k aggregate across sites, but lack of organ specificity limits confidence. No single comprehensive source.",weak,high,False,,,,
C0206245,"Amyloid Neuropathies, Familial",0.1,,incidence,8000,0.65,True,Hereditary Amyloidosis,"Familial amyloid polyneuropathy (FAP, TTR-related) incidence ~0.1 per 100k globally, higher in endemic areas (Portugal, Sweden, Japan). Rare but well-characterized genetic condition.",moderate,high,False,,Planté-Bordeneuve V et al. (2011). Familial amyloid polyneuropathy. Lancet Neurol. 10(12):1086-1097,https://pubmed.ncbi.nlm.nih.gov/22094129/,literature
C0206630,Endometrial Stromal Sarcoma,0.15,,incidence,12000,0.62,True,Uterine Sarcoma,Rare uterine malignancy representing ~10-15% of uterine sarcomas. Estimated ~0.1-0.2 per 100k women globally based on SEER and cancer registry data.,moderate,low,False,,D'Angelo E et al. (2011). Endometrial stromal sarcomas. Semin Diagn Pathol. 28(4):342-349,https://pubmed.ncbi.nlm.nih.gov/22195412/,literature
C0206650,Fibroadenoma,120,,incidence,9600000,0.58,False,,"Most common benign breast tumor, particularly in women 20-40 years old. Estimated ~120 per 100k based on clinical presentation data. Prevalence higher than incidence suggests, but incidence data from clinical registries. Confidence moderate due to underreporting (many asymptomatic).",moderate,moderate,False,,,,
C0206659,Embryonal Carcinoma,0.4,,incidence,32000,0.62,True,Non-seminomatous Germ Cell Tumors,"Reporting incidence. Embryonal carcinoma comprises ~40% of testicular germ cell tumors. With testicular cancer at ~6 per 100k men (3 per 100k total population), embryonal carcinoma estimated at ~0.4 per 100k.",moderate,moderate,False,,Horwich A et al. (2006). Testicular germ cell cancer. Lancet. 367(9512):754-765,https://pubmed.ncbi.nlm.nih.gov/16517276/,literature
C0206677,Adenomatous Polyps,,25000,prevalence,2000000000,0.68,True,Colorectal Polyps,"Reporting prevalence (existing cases), not incidence. Adenomatous polyps are benign precursor lesions found in ~25-30% of adults over age 50 (25,000 per 100k). Prevalence is the appropriate metric for this chronic, often asymptomatic condition.",moderate,moderate,False,,Lieberman DA et al. (2000). Prevalence of polyps greater than 9 mm in a consortium of diverse geographic areas. Clin Gastroenterol Hepatol. 3(8):798-805,https://pubmed.ncbi.nlm.nih.gov/16234009/,literature
C0206682,Follicular thyroid carcinoma,1.5,,incidence,120000,0.78,True,Thyroid Neoplasm,"Follicular thyroid carcinoma comprises ~10-15% of thyroid cancers. Global thyroid cancer incidence ~10-12 per 100k (GLOBOCAN 2005), so FTC ~1.5 per 100k. Second most common thyroid malignancy after papillary type.",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0206698,Cholangiocarcinoma,2.0,,incidence,160000,0.75,False,,Total cholangiocarcinoma (intrahepatic + extrahepatic) incidence ~2.0 per 100k globally circa 2005. Encompasses all bile duct malignancies. Significantly higher in Southeast Asia (Thailand ~85 per 100k) due to liver fluke infection.,strong,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C0206704,"Carcinoma, Large Cell",2.5,,incidence,200000,0.75,True,Lung Cancer,"Large cell carcinoma represents ~10-15% of lung cancers. Global lung cancer incidence ~20 per 100k (2005), thus large cell subtype ~2.5 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - lung cancer histological subtypes,https://gco.iarc.fr/,registry
C0206708,Cervical Intraepithelial Neoplasia,400,,incidence,32000000,0.75,False,,"CIN (all grades: CIN 1, 2, 3) detection rate from cervical screening programs globally. Estimated ~400 per 100k women screened per year based on WHO/HPV screening data circa 2005. Includes all grades of dysplasia. High geographic variation based on HPV prevalence and screening coverage.",strong,high,False,2005,Schiffman M et al. (2007). Human papillomavirus and cervical cancer. Lancet. 370:890-907,https://pubmed.ncbi.nlm.nih.gov/17826171/,literature
C0206734,Hemangioblastoma,0.18,,incidence,14400,0.7,True,Central Nervous System Neoplasm,Hemangioblastoma is a rare benign vascular tumor primarily of the cerebellum and spinal cord. Incidence approximately 0.15-0.2 per 100k person-years based on CNS tumor registries. Associated with von Hippel-Lindau disease in 20-30% of cases.,moderate,low,False,,CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors,https://www.cbtrus.org/,registry
C0220597,Adult Hodgkin Lymphoma,2.4,,incidence,192000,0.82,True,Hodgkin Lymphoma,Reporting incidence of new diagnoses. Adult Hodgkin lymphoma has global incidence of approximately 2.4 per 100k population. Bimodal age distribution with peaks in young adults and elderly. Data from GLOBOCAN 2005.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0220644,Childhood Hodgkin Lymphoma,0.3,,incidence,24000,0.78,True,Hodgkin Lymphoma,Reporting incidence of new diagnoses. Childhood Hodgkin lymphoma (ages 0-14) has incidence of approximately 0.3 per 100k total population (or 1.5 per 100k children). Data from GLOBOCAN and pediatric cancer registries.,strong,moderate,True,2005,Ferlay J et al. (2007). Estimates of cancer incidence and mortality in Europe in 2006. Ann Oncol. 18(3):581-592,https://pubmed.ncbi.nlm.nih.gov/17287242/,literature
C0220685,Achondrogenesis type 2,extremely rare,,incidence,extremely rare,0.3,True,Skeletal dysplasia,Lethal skeletal dysplasia caused by COL2A1 mutations. Extremely rare at <0.01 per 100k births based on case report frequency. Most cases are stillborn or die in neonatal period.,weak,unknown,False,,,,
C0221273,Juvenile polyp,50,1500,both,4000000,0.55,False,,"Juvenile polyps are benign hamartomatous polyps occurring in 1-2% of children (prevalence ~1500 per 100k). Incidence of clinical detection approximately 50 per 100k person-years based on pediatric gastroenterology studies. Most solitary and sporadic, distinct from juvenile polyposis syndrome.",moderate,moderate,False,,Hyer W et al. (2004). Juvenile polyposis syndrome. J Med Genet. 41(1):1-11,https://pubmed.ncbi.nlm.nih.gov/14729819/,literature
C0234535,Clonic Seizures,8,,incidence,640000,0.45,True,Seizure disorders,Purely clonic seizures are relatively uncommon subtype of epilepsy. Estimated ~8 per 100k based on epilepsy incidence (~50-70 per 100k) with clonic seizures representing ~10-15% of seizure types. Limited specific epidemiological data for this seizure classification.,weak,moderate,False,,,,
C0235782,Gallbladder Carcinoma,2.5,,incidence,200000,0.82,True,Biliary Tract Cancer,Gallbladder cancer incidence ~2-3 per 100k globally based on GLOBOCAN data. Shows high geographic variation (much higher in South America and South Asia).,strong,high,True,2005,Randi G et al. (2009). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 118(7):1591-1602,https://pubmed.ncbi.nlm.nih.gov/16397865/,literature
C0235833,Congenital diaphragmatic hernia,23.0,,incidence,1840000,0.78,False,,"Reporting incidence at birth. CDH occurs in approximately 2.3 per 10,000 live births (23 per 100k) based on congenital anomaly registries. Well-documented birth defect with consistent global data.",strong,low,False,,McGivern MR et al. (2015). Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study. Arch Dis Child Fetal Neonatal Ed. 100(2):F137-44,https://pubmed.ncbi.nlm.nih.gov/25411443/,registry
C0238052,"Xanthomatosis, Cerebrotendinous",extremely rare,,incidence,extremely rare,0.35,True,Lipid Storage Diseases,Cerebrotendinous xanthomatosis (CTX) is an extremely rare autosomal recessive disorder caused by CYP27A1 mutations. Estimated at <0.1 per 100k births based on case registries and prevalence estimates of 1-9 per million population.,weak,low,False,,,,
C0238461,Anaplastic thyroid carcinoma,0.15,,incidence,12000,0.78,True,Thyroid Carcinoma,"Anaplastic thyroid carcinoma represents 1-2% of all thyroid cancers. With thyroid cancer incidence ~6-8 per 100k globally in 2005, anaplastic subtype incidence ~0.15 per 100k person-years from cancer registry data.",strong,low,True,2005,Kebebew E et al. (2005). Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 103(7):1330-1335,https://pubmed.ncbi.nlm.nih.gov/15739211/,literature
C0238463,Papillary Thyroid Carcinoma,5.2,,incidence,416000,0.82,True,Thyroid Cancer,"Papillary thyroid carcinoma accounts for ~80% of thyroid cancers. Total thyroid cancer incidence ~6.5 per 100k globally in 2005, yielding ~5.2 per 100k for papillary subtype. Data from GLOBOCAN 2005.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0239211,Oedema auricular,,,,,0.0,False,,"Auricular edema is a clinical finding/symptom rather than a distinct disease entity. Can result from multiple etiologies including trauma, infection, allergic reaction, or inflammatory conditions. No meaningful incidence data as it's not tracked as a primary diagnosis.",none,unknown,False,,,,
C0242379,Malignant neoplasm of lung,35.0,,incidence,2800000,0.88,True,Lung Neoplasms,Lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally. Primarily refers to primary lung cancer in epidemiological reporting. Higher in males (~50 per 100k) than females (~20 per 100k).,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0243026,Sepsis,189,,incidence,15120000,0.72,False,,"Reporting incidence (new cases). Global estimate ~189 per 100k based on hospital surveillance data. Definition has evolved over time, affecting comparability.",strong,high,False,2017,Fleischmann C et al. (2016). Assessment of global incidence and mortality of hospital-treated sepsis. Am J Respir Crit Care Med. 193(3):259-272,https://pubmed.ncbi.nlm.nih.gov/26414292/,literature
C0262584,"Carcinoma, Small Cell",8.5,,incidence,680000,0.45,False,,"Small cell carcinoma without organ specification is problematic. If interpreted as small cell lung cancer (most common form), incidence ~8.5 per 100k. However, lack of anatomical specificity reduces confidence significantly as small cell carcinomas can occur in multiple organs.",moderate,high,True,2005,"GLOBOCAN 2005 lung cancer data, SCLC comprises ~15% of lung cancers",https://gco.iarc.fr/,registry
C0264133,Acquired flat foot,,2400,prevalence,192000000,0.45,True,Foot deformities,"Acquired flatfoot (posterior tibial tendon dysfunction) measured as prevalence, not incidence. Estimated ~2-3% adult prevalence (2,400 per 100k) based on orthopedic screening studies, but no systematic population-based registries.",moderate,moderate,False,,,,
C0264694,Chronic myocardial ischemia,150,4200,both,12000000,0.68,True,Myocardial Ischemia,"Chronic ischemic heart disease incidence ~150 per 100k, prevalence ~4200 per 100k (WHO 2005 estimates). Both metrics relevant for chronic condition. Moderate confidence due to diagnostic variability and limited 2005-specific sources.",moderate,high,False,2005,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C0266449,Congenital anomaly of brain,30.0,,incidence,39000,0.25,False,,"Aggregate BOTEC estimate summing major congenital brain malformations per 100k births: neural tube defects (10), hydrocephalus (8), microcephaly (5), holoprosencephaly (1), other malformations (6) = ~30 per 100k births. Heterogeneous group with significant geographic variation.",weak,high,False,,,,
C0268164,"Primary hyperoxaluria, type I",extremely rare,,incidence,extremely rare,0.45,True,Primary hyperoxaluria,Extremely rare autosomal recessive metabolic disorder. Estimated incidence <1 per million births (<0.1 per 100k) based on registry data from Europe. PH1 is the most common and severe form of primary hyperoxaluria.,moderate,moderate,False,,Cochat P et al. (1995). Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 10(11):1746-53,https://pubmed.ncbi.nlm.nih.gov/8559471/,literature
C0268381,Primary amyloidosis,1.0,,incidence,80000,0.65,True,Amyloidosis,AL (primary) amyloidosis incidence ~1.0 per 100k based on population-based studies. Rare plasma cell disorder with monoclonal light chain deposition.,moderate,low,False,,"Kyle RA et al. (2003). Incidence of AL amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 101(7):2462-3",https://pubmed.ncbi.nlm.nih.gov/12433690/,literature
C0269102,Endometrioma,,700,prevalence,56000000,0.65,True,Endometriosis,Endometrioma is a chronic condition measured by prevalence. Occurs in ~25% of endometriosis cases. Endometriosis affects ~10% of reproductive-age women; endometriomas estimated at ~700 per 100k total population (all ages/sexes).,moderate,moderate,False,,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,https://pubmed.ncbi.nlm.nih.gov/15541453/,literature
C0271994,Hereditary persistence of fetal hemoglobin thalassemia,,50,prevalence,4000000,0.45,True,Thalassemia,"HPFH with thalassemia is a genetic hemoglobinopathy. Prevalence-based metric appropriate for lifelong genetic condition. Estimated ~50 per 100k globally, but varies significantly by ethnicity (higher in Mediterranean, African, and Asian populations). Limited comprehensive global epidemiological data.",weak,high,False,,,,
C0275518,Acute infectious disease,,,,,0.0,False,,"Umbrella term too broad to estimate meaningfully - encompasses all acute bacterial, viral, fungal, and parasitic infections across all organ systems. Would require specification of pathogen type or organ system.",none,unknown,False,,,,
C0278510,Childhood Medulloblastoma,0.5,,incidence,40000,0.72,True,Medulloblastoma,"Reporting incidence of pediatric cases. Childhood medulloblastoma represents ~85% of all medulloblastomas, with incidence of ~6 per 100k in pediatric population (0-14 years), which equals ~0.5 per 100k when calculated against total population.",strong,low,False,2005,"Rickert CH, Paulus W (2001). Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Childs Nerv Syst. 17:503-511",https://pubmed.ncbi.nlm.nih.gov/11585301/,literature
C0278607,Adult Leiomyosarcoma,0.3,,incidence,24000,0.55,True,Soft Tissue Sarcoma,Leiomyosarcoma represents ~10-15% of soft tissue sarcomas. Estimated adult incidence ~0.3 per 100k based on SEER and European cancer registry data.,moderate,low,False,,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0278608,Adult Liposarcoma,0.4,,incidence,32000,0.6,True,Soft Tissue Sarcoma,"Most common soft tissue sarcoma in adults, representing ~20% of cases. Estimated incidence ~0.4 per 100k based on SEER registry data from early 2000s.",moderate,low,False,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001. Int J Cancer. 119(12):2922-2930",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C0278764,Adult Burkitt Lymphoma,0.3,,incidence,24000,0.65,True,Burkitt Lymphoma,Adult-onset Burkitt lymphoma represents ~20-30% of all Burkitt cases. Estimated ~0.3 per 100k adults in Western populations.,moderate,high,False,,Molyneux EM et al. (2012). Burkitt's lymphoma. Lancet. 379(9822):1234-44,https://pubmed.ncbi.nlm.nih.gov/22333947/,literature
C0278876,Adult Medulloblastoma,extremely rare,,incidence,extremely rare,0.55,True,Medulloblastoma,"Reporting incidence of adult cases. Adult medulloblastoma represents only ~10-15% of all medulloblastomas, with incidence <0.05 per 100k adults. Extremely rare with limited epidemiological data.",moderate,unknown,False,,Brandes AA et al. (2003). Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol. 66:223-246,https://pubmed.ncbi.nlm.nih.gov/18406622/,literature
C0278879,Childhood Burkitt Lymphoma,1.2,,incidence,96000,0.68,True,Burkitt Lymphoma,Childhood form represents 70-80% of Burkitt cases. Endemic areas (equatorial Africa): 5-10 per 100k children. Sporadic (Western): 0.2-0.5 per 100k. Global average ~1.2 per 100k children.,moderate,high,False,2005,Mbulaiteye SM et al. (2012). Burkitt lymphoma: beyond discoveries. Infect Agent Cancer. 7:3,https://pubmed.ncbi.nlm.nih.gov/22289355/,literature
C0279607,Adult Hepatocellular Carcinoma,11.5,,incidence,920000,0.82,True,Hepatocellular Carcinoma,"Age-specific HCC (adults). Global incidence ~11.5 per 100k from GLOBOCAN 2005, varies dramatically from <2 in North America/Europe to >25 in East Asia due to HBV/HCV prevalence. Most HCC cases occur in adults.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279626,Squamous cell carcinoma of esophagus,5.0,,incidence,400000,0.85,True,Esophageal Cancer,"Squamous cell carcinoma is the predominant esophageal cancer type globally (~85-90%). Global esophageal cancer incidence ~5.5-6 per 100k in 2005, thus squamous cell ~5 per 100k.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0279632,Adult Acute Megakaryoblastic Leukemia,extremely rare,,incidence,extremely rare,0.5,True,Adult Acute Myeloid Leukemia,"AMKL is extremely rare in adults, representing <1% of adult AML cases. With adult AML incidence of 3-4 per 100k per year, adult AMKL incidence is <0.03-0.04 per 100k. Much rarer than childhood form. Classified as extremely rare.",moderate,low,False,,SEER Cancer Statistics Review,https://seer.cancer.gov/csr/,registry
C0279650,Childhood Acute Megakaryoblastic Leukemia,extremely rare,,incidence,extremely rare,0.55,True,Childhood Acute Myeloid Leukemia,"AMKL (AML-M7) represents 5-10% of childhood AML cases. With childhood AML incidence of ~0.7 per 100k children per year, childhood AMKL is approximately 0.035-0.07 per 100k children, or <0.02 per 100k total population. Classified as extremely rare (<0.1 per 100k).",moderate,low,False,,SEER Pediatric Monograph: Childhood Cancer by ICCC,https://seer.cancer.gov/,registry
C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,5.8,,incidence,464000,0.78,True,Renal Cell Carcinoma,"Clear cell RCC represents ~70-75% of all renal cell carcinomas. Global RCC incidence ~8.2 per 100k from GLOBOCAN 2005, therefore clear cell subtype ~5.8 per 100k. High confidence based on cancer registry data.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - kidney cancer data with subtype distribution from pathology series,https://gco.iarc.fr/,registry
C0279984,Childhood Liposarcoma,extremely rare,,incidence,extremely rare,0.4,True,Liposarcoma,Liposarcoma is extremely rare in children (<5% of pediatric soft tissue sarcomas). Pediatric soft tissue sarcomas: ~0.9 per 100k; liposarcoma represents <0.05 per 100k children. Case reports only.,weak,unknown,False,,Ferrari A et al. (2005). Soft tissue sarcomas in children and adolescents: the prognostic role of tumor size in relation to patient body size. J Clin Oncol. 23(2):371-6,https://pubmed.ncbi.nlm.nih.gov/15637399/,literature
C0279986,Childhood Leiomyosarcoma,extremely rare,,incidence,extremely rare,0.35,True,Leiomyosarcoma,"Leiomyosarcoma in pediatric population is exceedingly rare, <0.01 per 100k children. Comprises <2% of pediatric soft tissue sarcomas based on case series.",weak,unknown,False,,,,
C0280100,Solid Neoplasm,,,,,0.0,False,,"Unmappable umbrella term encompassing all solid tumors (breast, lung, colon, prostate, stomach, liver, etc.) versus hematological malignancies. Too broad and heterogeneous to provide meaningful aggregate estimate - incidence rates vary from <1 per 100k for rare sarcomas to >50 per 100k for common epithelial cancers.",none,high,False,,,,
C0280217,"stage, non-small cell lung cancer",25.5,,incidence,2040000,0.72,True,Lung Cancer,"Interpreting as non-small cell lung cancer (NSCLC), which comprises ~85% of all lung cancers. Global lung cancer incidence 2005: ~30 per 100k. NSCLC: ~25.5 per 100k. Confidence reduced due to ambiguous CUI terminology.",strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0280324,Laryngeal Squamous Cell Carcinoma,1.5,,incidence,120000,0.82,True,Laryngeal Cancer,"Laryngeal SCC represents ~95% of laryngeal cancers. GLOBOCAN 2005 data shows laryngeal cancer incidence ~1.6 per 100k globally, thus SCC component ~1.5 per 100k. Varies significantly by smoking prevalence (higher in Europe, lower in Africa).",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0281508,Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.38,True,Soft Tissue Sarcoma,"Extremely rare aggressive sarcoma with EWS-WT1 fusion, primarily affecting children and young adults. Estimated <0.03 per 100k based on sarcoma registry data and case series.",weak,unknown,False,,,,
C0282612,Prostatic Intraepithelial Neoplasias,25.0,,incidence,2000000,0.45,True,Prostatic Neoplasms,PIN is a precancerous lesion found incidentally during prostate biopsy. Not systematically tracked in registries. Estimated ~25 per 100k based on prostate biopsy rates (~5-8% detection in screened men aged >50). Low-moderate confidence due to screening-dependent detection.,weak,high,False,,,,estimate
C0302592,Cervix carcinoma,15.2,,incidence,1216000,0.88,True,Cervical Cancer,Cervical carcinoma incidence from GLOBOCAN 2005 data: ~15.2 per 100k women globally. HPV-related cancer with wide geographic variation based on screening programs.,strong,high,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 6",https://gco.iarc.fr/,registry
C0333307,Superficial ulcer,,,,,0.0,False,,"Unmappable - 'superficial ulcer' is a generic clinical finding without anatomical or etiological specificity. Could refer to skin ulcers, oral ulcers, gastric ulcers, etc. Too broad and non-specific to provide meaningful population-based incidence estimate.",none,unknown,False,,,,
C0333516,Tumor necrosis,,,,,0.0,False,,"Pathological finding/process occurring within tumors, not an independent disease entity. No meaningful incidence rate can be assigned to a histological feature.",none,unknown,False,,,,
C0333875,High-Grade Squamous Intraepithelial Lesions,150.0,,incidence,12000000,0.52,True,Squamous Intraepithelial Lesions,"HSIL (cervical) detection highly dependent on screening intensity. In screened populations, ~1-2% annual detection rate among women aged 25-65. Global estimate ~150 per 100k women accounting for variable screening access. Screening-dependent artifact.",moderate,high,False,,,,estimate
C0334307,Tubulovillous adenoma,45.0,,incidence,3600000,0.55,True,Colorectal Adenoma,Tubulovillous adenomas comprise ~15-20% of all colorectal adenomas detected during screening. Estimated ~45 per 100k based on colonoscopy screening data from early 2000s.,moderate,moderate,False,,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,https://pubmed.ncbi.nlm.nih.gov/10900274/,literature
C0334463,Malignant Fibrous Histiocytoma,0.45,,incidence,36000,0.68,True,Soft Tissue Sarcoma,MFH (now called undifferentiated pleomorphic sarcoma) was historically the most common adult STS subtype at ~10-15% of cases. Approximately 0.45 per 100k based on SEER data.,moderate,low,False,2005,Fletcher CDM (2006). The evolution of the classification of soft tissue tumours - an update based on the new WHO classification. Histopathology. 48(1):3-12,https://pubmed.ncbi.nlm.nih.gov/16359532/,literature
C0334529,"Hydatidiform Mole, Partial",1.0,,incidence,80000,0.5,True,Gestational trophoblastic disease,"Specific subtype of molar pregnancy occurring in approximately 0.5-1 per 1000 pregnancies. Estimated at ~1.0 per 100k person-years. Less common than complete mole, diagnosed by histopathology and genetic analysis.",moderate,moderate,False,,Seckl MJ et al. (2010). Gestational trophoblastic disease. Lancet. 376(9742):717-729,https://pubmed.ncbi.nlm.nih.gov/20673583/,literature
C0334590,Anaplastic Oligodendroglioma,0.18,,incidence,14400,0.65,True,Oligodendroglioma,Rare malignant brain tumor (WHO grade III) with incidence ~0.18 per 100k based on CBTRUS and SEER data. Represents approximately 3-5% of all gliomas.,strong,low,False,,CBTRUS Statistical Report: Primary Brain and CNS Tumors,https://www.cbtrus.org/,registry
C0338831,Manic,15.0,,incidence,1200000,0.65,True,Bipolar Disorder,Manic episodes are primarily associated with Bipolar Disorder. Using bipolar disorder incidence as proxy: ~15 per 100k person-years based on epidemiological literature. Confidence moderate due to lack of 2005-specific data and symptom-based rather than disease-based classification.,moderate,moderate,False,,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature
C0339535,"Night blindness, congenital stationary",extremely rare,,incidence,extremely rare,0.35,False,,Congenital stationary night blindness (CSNB) is a rare hereditary retinal disorder. Birth incidence estimated at <0.1 per 100k based on case reports and genetic registries. Limited epidemiological data available.,weak,unknown,False,,,,
C0339573,"Glaucoma, Primary Open Angle",190,,incidence,15200000,0.72,True,"Glaucoma, Open-Angle","POAG is the most common subtype of open-angle glaucoma, accounting for ~95% of cases. Incidence ~190 per 100k based on population-based cohort studies.",strong,moderate,False,2007,"Quigley HA, Broman AT (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262-267",https://pubmed.ncbi.nlm.nih.gov/16488940/,literature
C0339789,Congenital deafness,4.0,,incidence,320000,0.75,False,,"Reporting incidence of congenital hearing loss at birth. Global prevalence ~1-3 per 1000 births; with birth rate ~20 per 1000 population, yields ~4 new cases per 100k person-years.",strong,moderate,False,,Smith RJH et al. (2005). Sensorineural hearing loss in children. Lancet. 365(9462):879-890,https://pubmed.ncbi.nlm.nih.gov/15752533/,literature
C0342257,Complications of Diabetes Mellitus,,,,,0.0,False,,"Unmappable: This represents complications arising from pre-existing diabetes (retinopathy, nephropathy, neuropathy, CVD complications), not incident disease entities in general population. Incidence of complications is measured within diabetic populations, not per 100k general population.",none,unknown,False,,,,
C0342386,Follicle stimulating hormone deficiency,0.3,,incidence,24000,0.38,True,Hypogonadotropic Hypogonadism,"Rare endocrine disorder, component of hypogonadotropic hypogonadism. Estimated ~0.3 per 100k based on limited case series and endocrine registry data. Low-moderate confidence due to sparse epidemiological data.",weak,unknown,False,,,,
C0342749,GLYCOGEN STORAGE DISEASE Ic,extremely rare,,incidence,extremely rare,0.4,True,Glycogen Storage Disease Type I,"GSD type Ic (G6PT deficiency) is extremely rare. GSD type I overall occurs in ~1 per 100k births, with type Ic representing ~10-15% of GSD-I cases. Estimated <0.015 per 100k births based on case series.",weak,low,False,,Chou JY et al. (2002). Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2(2):121-43,https://pubmed.ncbi.nlm.nih.gov/11949930/,literature
C0343641,Human papilloma virus infection,2500,,incidence,200000000,0.65,False,,"Reporting incidence of new HPV infections. Global estimates suggest ~2,500 per 100k person-years for sexually active populations, though varies significantly by region and age group. Limited to general epidemiological estimates rather than registry data.",moderate,high,False,,WHO/ICO Information Centre on HPV and Cervical Cancer,,estimate
C0345905,Intrahepatic Cholangiocarcinoma,1.5,,incidence,120000,0.75,True,Cholangiocarcinoma,"Intrahepatic cholangiocarcinoma incidence varies by region (0.5-2 in Western countries, 2-6 in Asia due to liver flukes). Global average ~1.5 per 100k based on registry data.",strong,high,False,2008,Khan SA et al. (2008). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214597/,literature
C0345967,Malignant mesothelioma,1.3,,incidence,104000,0.75,True,Mesothelioma,"Reporting incidence (new diagnoses). Global mesothelioma incidence ~1-1.5 per 100k from WHO and IARC data circa 2005, strongly associated with asbestos exposure.",strong,high,False,2005,Peto J et al. (1999). The European mesothelioma epidemic. Br J Cancer. 79(3-4):666-72; WHO mortality data 2005,https://pubmed.ncbi.nlm.nih.gov/10027347/,literature
C0346647,Malignant neoplasm of pancreas,8.2,,incidence,656000,0.88,True,Digestive system neoplasms,"Reporting incidence. Pancreatic cancer incidence from GLOBOCAN 2005 shows ~8.2 per 100k globally, with higher rates in developed countries (10-12 per 100k) and lower in developing regions (5-7 per 100k).",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0375023,Respiratory syncytial virus (RSV) infection,3300,,incidence,264000000,0.58,True,Viral respiratory infection,"Common acute viral respiratory infection, particularly in children. Global estimate ~33 million cases annually in children <5 years from WHO data, translating to ~3,300 per 100k population-wide (heavily skewed to pediatric).",moderate,high,False,2005,Nair H et al. (2010). Global burden of acute lower respiratory infections due to RSV in young children. Lancet. 375(9725):1545-55,https://pubmed.ncbi.nlm.nih.gov/20399493/,literature
C0376358,Malignant neoplasm of prostate,25.3,,incidence,2024000,0.88,False,,"Synonym for prostate cancer. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",strong,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0376544,Hematopoietic Neoplasms,28.0,,incidence,2240000,0.25,False,,"Aggregate BOTEC estimate summing major hematopoietic malignancies: leukemias (~10), non-Hodgkin lymphoma (~7), Hodgkin lymphoma (~2.5), multiple myeloma (~4.5), MDS/MPN (~4) = ~28 per 100k. Heterogeneous group with varying biology and prognosis.",weak,moderate,False,,,,
C0376618,Endotoxemia,19.0,,incidence,1520000,0.45,False,,"Endotoxemia typically occurs with gram-negative sepsis. Estimated at ~19 per 100k based on severe sepsis incidence data, but endotoxemia as standalone diagnosis is poorly characterized in literature. Confidence reduced due to vague clinical definition and limited direct epidemiological data.",moderate,high,False,,,,
C0392477,Congenital flat foot,200,,incidence,160000,0.4,True,Flatfoot,"Congenital flatfoot incidence estimated at ~200 per 100k births based on pediatric orthopedic literature. However, definitions vary widely (flexible vs rigid, physiologic vs pathologic), and most cases resolve spontaneously.",weak,moderate,False,,,,
C0393738,Chronic tension-type headache,,2200,prevalence,176000000,0.72,True,Tension-type headache,"Chronic headache disorder measured by prevalence, not incidence. Global prevalence approximately 2-2.5% (2,200 per 100k) based on epidemiological studies. Chronic form represents subset of all tension-type headaches.",strong,moderate,False,2005,Stovner LJ et al. (2007). The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 27(3):193-210,https://pubmed.ncbi.nlm.nih.gov/17381554/,literature
C0398650,Immune thrombocytopenic purpura,3.3,,incidence,264000,0.75,False,,"ITP incidence ~3.3 per 100k person-years globally. Data from population-based studies show consistent estimates of 2-4 per 100k in adults, slightly higher in children.",strong,low,False,2005,Terrell DR et al. (2010). The incidence of immune thrombocytopenic purpura in children and adults. Blood. 116(22):4884-4886,https://pubmed.ncbi.nlm.nih.gov/20805365/,literature
C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",extremely rare,,incidence,extremely rare,0.45,True,Hyper-IgM Syndrome,"X-linked hyper-IgM syndrome (CD40L deficiency) is an extremely rare primary immunodeficiency with estimated incidence <0.1 per 100k births, approximately 2 per million live births. Limited to case series and registry data.",weak,low,False,,Notarangelo LD et al. (2006). Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 124(6):1161-78,https://pubmed.ncbi.nlm.nih.gov/20004777/,literature
C0403809,Primary spermatogenic failure,,800,prevalence,64000000,0.58,True,Male Infertility,"Primary spermatogenic failure is a chronic condition causing male infertility, measured by prevalence. Male infertility affects ~7% of men; primary spermatogenic failure accounts for ~30-40% of cases. Estimated ~800 per 100k total population (all ages/sexes).",moderate,moderate,False,,Agarwal A et al. (2015). A unique view on male infertility around the globe. Reprod Biol Endocrinol. 13:37,https://pubmed.ncbi.nlm.nih.gov/25928197/,literature
C0409974,Lupus Erythematosus,5.1,,incidence,408000,0.78,False,,"Systemic lupus erythematosus (SLE) global average incidence ~5 per 100k person-years. Significant variation by ethnicity (higher in African, Hispanic, Asian populations) and gender (9:1 female:male ratio).",strong,high,False,2005,Pons-Estel GJ et al. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 39(4):257-268,https://pubmed.ncbi.nlm.nih.gov/19136143/,literature
C0409979,Neonatal Systemic lupus erythematosus,extremely rare,,incidence,extremely rare,0.35,True,Systemic Lupus Erythematosus,Neonatal lupus occurs in infants of mothers with anti-Ro/La antibodies. Estimated <0.1 per 100k births globally based on case series and registry data. Passively acquired autoimmune condition with limited systematic epidemiological studies.,weak,moderate,False,,,,
C0410528,Skeletal dysplasia,4.0,,incidence,5200,0.25,False,,"Aggregate BOTEC estimate summing major skeletal dysplasias per 100k births: achondroplasia (0.4), osteogenesis imperfecta (0.6), thanatophoric dysplasia (0.3), other lethal dysplasias (0.5), other non-lethal types (2.2) = ~4 per 100k births. Heterogeneous group of >400 distinct conditions.",weak,moderate,False,,,,
C0424295,Hyperactive behavior,,,,,0.0,False,,"Hyperactive behavior is a symptom or behavioral pattern, not a disease entity. It manifests in multiple conditions (ADHD, bipolar disorder, hyperthyroidism, etc.) and cannot be mapped to a specific incidence rate. Unmappable as a symptom descriptor rather than a disease.",none,unknown,False,,,,
C0424605,Developmental delay (disorder),,2000,prevalence,160000000,0.62,False,,"Developmental delay (broader than global DD) measured as prevalence. Includes delays in single or multiple domains, affects ~2% of children (2,000 per 100k). Prevalence appropriate for chronic developmental condition.",moderate,moderate,False,,Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0431380,Cortical Dysplasia,3.5,,incidence,280000,0.45,True,Malformations of Cortical Development,Focal cortical dysplasia birth incidence estimated at ~3-4 per 100k based on epilepsy surgery series and autopsy studies. True population incidence uncertain as many cases remain undiagnosed. Data quality limited by detection bias.,weak,moderate,False,,,,estimate
C0442874,Neuropathy,400,,incidence,32000000,0.23,False,,"Aggregate BOTEC estimate summing major neuropathy types: diabetic neuropathy (~180), chemotherapy-induced peripheral neuropathy (~60), idiopathic peripheral neuropathy (~80), alcoholic neuropathy (~30), other causes (~50). Total ~400 per 100k. Highly heterogeneous umbrella term with significant variation in etiology and severity.",weak,high,False,,,,
C0457506,Reactive thrombocytosis,250,,incidence,20000000,0.45,False,,"Reporting incidence of new diagnoses. Reactive (secondary) thrombocytosis is a common laboratory finding resulting from infections, inflammation, iron deficiency, malignancy, or post-surgical states. Estimated ~250 per 100k based on hospital studies, but true incidence difficult to quantify as it's a laboratory finding rather than primary disease.",weak,moderate,False,,,,
C0474808,Follicular neoplasm,,,,,0.0,False,,"Umbrella term covering follicular neoplasms across multiple organ systems including thyroid follicular adenomas, follicular thyroid carcinoma, follicular lymphoma, and ovarian follicular tumors. Each has vastly different incidence rates and clinical significance. Unmappable without anatomic specification.",none,high,False,,,,
C0474822,Benign pheochromocytoma,0.7,,incidence,56000,0.65,True,Pheochromocytoma,Benign pheochromocytomas represent ~90% of all pheochromocytomas (total incidence ~0.8 per 100k). Estimated at 0.7 per 100k based on endocrine tumor registry data.,moderate,low,False,,"Beard CM et al. (1983). Occurrence of pheochromocytoma in Rochester, Minnesota, 1950-1979. Mayo Clin Proc. 58:802-804",https://pubmed.ncbi.nlm.nih.gov/6645626/,literature
C0494165,Secondary malignant neoplasm of liver,25,,incidence,2000000,0.6,True,Liver neoplasm,"Liver metastases from primary cancers (colorectal, pancreatic, breast, lung). Estimated ~25 per 100k person-years based on metastatic disease patterns. More common than primary liver cancer. Exact incidence challenging to quantify as registries focus on primary cancer sites.",moderate,moderate,False,,,,
C0494475,Tonic - clonic seizures,25.0,,incidence,2000000,0.55,True,Epilepsy,Tonic-clonic seizures (grand mal) are the most common seizure type in epilepsy. Estimating ~40-50% of epilepsy incidence (50-70 per 100k) = ~25 per 100k. Moderate confidence due to classification complexity.,moderate,moderate,False,,Banerjee PN et al. (2009). The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 85(1):31-45,https://pubmed.ncbi.nlm.nih.gov/19369037/,literature
C0497156,Lymphadenopathy,,,,,0.0,False,,"Lymphadenopathy is a clinical sign (enlarged lymph nodes), not a disease entity. It's a manifestation of hundreds of underlying conditions including infections, malignancies, and autoimmune diseases. Unmappable without specification of underlying etiology.",none,unknown,False,,,,
C0497327,Dementia,118.0,,incidence,9440000,0.85,False,,"Umbrella term including Alzheimer's disease, vascular dementia, and other forms. Alzheimer's Disease International 2005 estimated 7.7 million new dementia cases globally per year, approximately 118 per 100k person-years. Strong epidemiological data.",strong,moderate,True,2005,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature
C0521158,Recurrent tumor,,,,,0.0,False,,Not a disease entity but a clinical descriptor of tumor recurrence. Could refer to recurrence of any cancer type. Cannot assign meaningful incidence rate to a temporal modifier.,none,unknown,False,,,,
C0521170,Osteoporotic Fractures,500,,incidence,40000000,0.72,True,Osteoporosis,"Reporting incidence of new osteoporotic fractures (hip, spine, wrist). Global estimate ~500 per 100k person-years based on IOF epidemiological data. Significant age and geographic variation.",moderate,high,False,2007,"Johnell O, Kanis JA. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 17(12):1726-33",https://pubmed.ncbi.nlm.nih.gov/16983459/,literature
C0524620,Metabolic Syndrome X,,22000,prevalence,1760000000,0.72,False,,"Cluster of metabolic risk factors (obesity, hypertension, dyslipidemia, insulin resistance). Measured as prevalence, not incidence. Global adult prevalence approximately 22% (22,000 per 100k) circa 2005, with increasing trends.",strong,high,False,2005,Eckel RH et al. (2005). The metabolic syndrome. Lancet. 365(9468):1415-1428,https://pubmed.ncbi.nlm.nih.gov/15836891/,literature
C0524851,Neurodegenerative Disorders,350,,incidence,28000000,0.25,False,,"Aggregate BOTEC estimate summing major neurodegenerative conditions: Alzheimer's disease (~250 per 100k in elderly populations), Parkinson's disease (~15 per 100k), ALS (~2 per 100k), Huntington's (~0.5 per 100k), vascular dementia (~50 per 100k), other dementias (~30 per 100k). Total ~350 per 100k. Highly heterogeneous umbrella term with significant age-stratification effects.",weak,high,False,,,,estimate
C0525045,Mood Disorders,,9500,prevalence,760000000,0.28,False,,"Aggregate BOTEC summing major mood disorders: major depressive disorder (~6000 per 100k), dysthymia (~3600 per 100k), bipolar disorder (~1200 per 100k). Total ~9,500 per 100k. Heterogeneous conditions with diagnostic overlap and comorbidity.",weak,moderate,False,2004,,,estimate
C0549473,Thyroid carcinoma,5.1,,incidence,408000,0.88,False,,"Well-defined cancer with robust registry data. GLOBOCAN 2005 reports global thyroid cancer incidence at ~5.1 per 100k, with higher rates in women (3:1 ratio).",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0549567,Pigmentation Disorders,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes congenital conditions (albinism, café au lait spots), acquired disorders (vitiligo, melasma), hyper- and hypopigmentation conditions with vastly different etiologies, prevalence rates, and clinical significance. Mix of incidence-based (acquired) and prevalence-based (congenital) conditions. Aggregate estimate not clinically meaningful.",none,high,False,,,,
C0555198,Malignant Glioma,5.5,,incidence,440000,0.8,False,,"Umbrella term for malignant glial tumors including glioblastoma (~3.5), anaplastic astrocytoma (~0.6), anaplastic oligodendroglioma (~0.2), and other high-grade gliomas. Total incidence ~5.5 per 100k based on cancer registry data.",strong,low,False,,CBTRUS and global cancer registries,https://www.cbtrus.org/,registry
C0557874,Global developmental delay,,1500,prevalence,120000000,0.65,True,Developmental delay,"Global developmental delay measured as prevalence in pediatric populations. Affects ~1-3% of children (using 1.5% estimate = 1,500 per 100k). Incidence not appropriate for chronic developmental condition.",moderate,moderate,False,,Shevell M et al. (2003). Practice parameter: evaluation of the child with global developmental delay. Neurology. 60(3):367-380,https://pubmed.ncbi.nlm.nih.gov/12578916/,literature
C0585442,Osteosarcoma of bone,0.35,,incidence,28000,0.72,True,Osteosarcoma,Reporting incidence at ~0.35 per 100k person-years. Osteosarcoma of bone is a specific anatomical subtype with incidence of 3-4 per million globally based on SEER and international cancer registry data.,strong,low,False,,Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-43,https://pubmed.ncbi.nlm.nih.gov/19197972/,literature
C0596263,Carcinogenesis,,,,,0.0,False,,"Unmappable: Carcinogenesis is a biological process (cancer formation), not a specific disease entity. Cannot assign meaningful incidence to a process descriptor.",none,unknown,False,,,,
C0598766,Leukemogenesis,,,,,0.0,False,,"Unmappable: Leukemogenesis is a biological process term (the formation/development of leukemia), not a disease entity. Cannot assign meaningful incidence to a process descriptor. For leukemia incidence data, would need specific leukemia type CUIs.",none,unknown,False,,,,
C0600139,Prostate carcinoma,25.3,,incidence,2024000,0.88,False,,"Second most common cancer in men globally. GLOBOCAN 2005 estimates ~680,000 new cases per year, approximately 25.3 per 100k population (both sexes) or ~50 per 100k men. High geographic variation: higher in developed countries.",strong,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C0678213,Complete hydatidiform mole,1.8,,incidence,144000,0.62,True,Hydatidiform Mole,Complete moles represent ~70-75% of all molar pregnancies. Using total molar pregnancy rate and applying this proportion yields ~1.8 per 100k total population globally.,moderate,high,False,,"Berkowitz RS, Goldstein DP. (2009). Clinical practice: Molar pregnancy. N Engl J Med. 360:1639-1645",https://pubmed.ncbi.nlm.nih.gov/19369669/,literature
C0678222,Breast Carcinoma,37.4,,incidence,2992000,0.92,False,,Synonymous with malignant neoplasm of breast. GLOBOCAN 2002 data: ~37 per 100k global population. Breast carcinoma represents >95% of breast malignancies.,strong,high,True,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0684249,Carcinoma of lung,19.5,,incidence,1560000,0.86,True,Lung Cancer,Lung carcinomas (non-small cell) represent approximately 85% of all lung cancers. GLOBOCAN 2005 reports global lung cancer incidence of ~23 per 100k; carcinomas specifically ~19.5 per 100k. High confidence from robust cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0699790,Colon Carcinoma,17.5,,incidence,1400000,0.88,True,Colorectal Cancer,"Colon cancer (excluding rectum) accounts for ~70% of colorectal cancer. GLOBOCAN 2002 data shows global colorectal cancer incidence ~25 per 100k, yielding colon-specific rate of ~17.5 per 100k.",strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0699791,Stomach Carcinoma,17.5,,incidence,1400000,0.85,True,Stomach Neoplasms,"Gastric cancer incidence from GLOBOCAN 2005: ~17.5 per 100k globally. Dramatic geographic variation: >40 per 100k in East Asia (Japan, Korea, China) vs <5 per 100k in North America, driven by H. pylori prevalence and dietary factors.",strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0699885,Carcinoma of bladder,9.0,,incidence,720000,0.88,False,,Bladder carcinoma (predominantly urothelial) with global incidence ~9.0 per 100k from GLOBOCAN 2005. Higher in males (~14) than females (~4). Strong cancer registry data.,strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0700095,Central neuroblastoma,extremely rare,,incidence,extremely rare,0.3,True,Neuroblastoma,"Central (CNS) neuroblastoma extremely rare, <0.01 per 100k. Most neuroblastomas are peripheral (adrenal/sympathetic chain). Limited case reports only.",weak,unknown,False,,,,
C0740457,Malignant neoplasm of kidney,7.6,,incidence,608000,0.9,True,Urological Neoplasm,"Reporting incidence of all malignant kidney cancers. GLOBOCAN 2005 estimates ~7.6 per 100k globally. Includes renal cell carcinoma (90%), transitional cell carcinoma, Wilms tumor, and other rare types. Higher in developed countries (10-15 per 100k).",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C0746102,Chronic lung disease,,,,,0.0,False,,"Umbrella term covering multiple distinct conditions (COPD, chronic bronchitis, bronchiectasis, interstitial lung diseases) with vastly different etiologies and incidence rates. Too heterogeneous to provide meaningful aggregate estimate.",none,high,False,,,,
C0748540,"Scleroderma, Limited",1.2,,incidence,96000,0.65,True,Systemic Sclerosis,"Limited cutaneous systemic sclerosis (lcSSc) represents approximately 60-70% of systemic sclerosis cases. Total SSc incidence ~1.5-2 per 100k, so lcSSc ~1.2 per 100k.",moderate,moderate,False,2005,"Mayes MD et al. (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 48(8):2246-55",https://pubmed.ncbi.nlm.nih.gov/12905479/,literature
C0751606,Adult Acute Lymphocytic Leukemia,0.7,,incidence,56000,0.72,True,Acute Lymphoblastic Leukemia,"Adult ALL (age 20+) represents ~20-30% of all ALL cases. Overall ALL incidence ~1.8 per 100k globally, with adults comprising ~0.7 per 100k. Based on SEER and international cancer registry data circa 2005.",strong,low,False,2005,"Howlader N et al. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute.",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C0751674,Lymphangioleiomyomatosis,0.1,0.3,both,8000,0.58,False,,"LAM is extremely rare, affecting primarily women of reproductive age. Incidence ~0.1 per 100k (new diagnoses), prevalence ~0.3 per 100k based on registry studies.",moderate,low,False,,Harknett EC et al. (2011). Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 104(11):971-979,https://pubmed.ncbi.nlm.nih.gov/21715468/,literature
C0795801,Trisomy 2,extremely rare,,,extremely rare,0.25,False,Chromosomal Abnormality,Trisomy 2 is typically embryonic lethal and incompatible with life. Most cases result in early spontaneous abortion. Live births are extraordinarily rare with fewer than 10 documented cases globally. Estimated <0.001 per 100k births based on prenatal diagnosis studies.,weak,unknown,False,,,,
C0796003,Juberg-Marsidi syndrome,extremely rare,,incidence,extremely rare,0.25,True,X-linked intellectual disability,"Extremely rare X-linked syndrome causing severe intellectual disability, growth retardation, and deafness. <50 cases reported in literature. Estimated <0.01 per 100k births.",weak,unknown,False,,,,
C0812413,Malignant Pleural Mesothelioma,1.5,,incidence,120000,0.78,True,Mesothelioma,"Reporting incidence of malignant pleural mesothelioma. Global incidence ~1.5 per 100k based on GLOBOCAN data, with very high geographic variation (10-40x higher in regions with historical asbestos exposure like Australia, UK).",strong,high,True,2005,"GLOBOCAN 2005, International Agency for Research on Cancer",https://gco.iarc.fr/,registry
C0848558,Hypospadias,500,,incidence,40000000,0.78,False,,Reporting incidence at birth. Hypospadias affects approximately 1 in 200 male births globally (500 per 100k male births). Rates vary from 200-800 per 100k male births by region.,strong,moderate,False,,Paulozzi LJ et al. (1999). Hypospadias trends in two US surveillance systems. Pediatrics. 100(5):831-4,https://pubmed.ncbi.nlm.nih.gov/9346982/,registry
C0852654,21-hydroxylase deficiency,0.14,,incidence,11200,0.82,True,Congenital Adrenal Hyperplasia,"Identical to C2936858. 21-hydroxylase deficiency is the enzymatic basis of classic CAH, occurring in ~1 per 15,000 births, translating to ~0.14 per 100k person-years.",strong,moderate,False,,Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,https://pubmed.ncbi.nlm.nih.gov/20823466/,literature
C0853879,Invasive carcinoma of breast,20.0,,incidence,1600000,0.85,True,Breast Cancer,"Invasive breast carcinoma comprises ~80% of all breast cancers (includes invasive ductal and lobular). Global breast cancer incidence 2005: ~50 per 100k women, ~25 per 100k overall. Invasive forms represent ~80%, yielding ~20 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C0854802,Recurrent Chronic Lymphoid Leukemia,,,,,0.0,True,Chronic Lymphocytic Leukemia,"Unmappable - 'Recurrent' describes a clinical state (disease relapse after treatment) rather than population incidence. Recurrence occurs in CLL patients, not the general population. Cannot provide meaningful population-based incidence rate.",none,unknown,False,,,,
C0878773,Overactive Bladder,,12000,prevalence,960000000,0.72,False,,"Chronic symptom syndrome measured as prevalence, not incidence. Population-based surveys show ~12% of adults globally have OAB symptoms (12,000 per 100k). EPIC study and similar surveys provide robust prevalence data.",strong,moderate,False,2006,"Irwin DE et al. (2006). Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 50(6):1306-14",https://pubmed.ncbi.nlm.nih.gov/17049716/,literature
C0919267,ovarian neoplasm,12,,incidence,960000,0.25,False,,Aggregate BOTEC estimate for umbrella term including both malignant (6.6) and benign ovarian neoplasms requiring clinical intervention (~5-6). Total ~12 per 100k women. Heterogeneous category with variable clinical significance.,weak,moderate,False,,,,
C0940937,precancerous lesions,,,,,0.0,False,,"Umbrella term covering heterogeneous precancerous lesions across multiple organ systems (cervical dysplasia, colorectal adenomas, oral leukoplakia, actinic keratosis, Barrett's esophagus, etc.) with vastly different incidence rates and clinical significance. Too broad to estimate meaningfully.",none,unknown,False,,,,
C0948089,Acute Coronary Syndrome,90.0,,incidence,7200000,0.75,False,,"ACS encompasses STEMI, NSTEMI, and unstable angina. Global incidence estimated at ~90 per 100k person-years based on WHO cardiovascular disease data circa 2005. High variation: 150-200 per 100k in developed countries, 50-70 in developing regions.",strong,high,False,2005,Yusuf S et al. (2001). Global burden of cardiovascular diseases. Circulation. 104(22):2746-2753,https://pubmed.ncbi.nlm.nih.gov/11723030/,literature
C1134719,Invasive Ductal Breast Carcinoma,35.2,,incidence,2816000,0.82,True,Breast Cancer,"Invasive ductal carcinoma comprises ~80% of invasive breast cancers. Global breast cancer incidence from GLOBOCAN 2005: ~44 per 100k, invasive ductal subset estimated at ~35 per 100k. High confidence based on well-documented histological distribution.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) with histological subtype distribution,https://gco.iarc.fr/,registry
C1135868,Gestational Trophoblastic Neoplasms,2.5,,incidence,200000,0.72,False,,"Includes hydatidiform mole and choriocarcinoma. Global incidence ~1-2 per 1000 pregnancies, translating to ~2.5 per 100k person-years. Higher in Asia (up to 12 per 1000 pregnancies), lower in North America/Europe (0.6-1.1 per 1000).",strong,high,False,,"Lurain JR (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C1140680,Malignant neoplasm of ovary,6.6,,incidence,528000,0.88,False,,"Ovarian cancer incidence from GLOBOCAN 2005 data: approximately 6.6 per 100,000 women globally. Well-documented in cancer registries.",strong,moderate,True,2005,"Ferlay J et al. (2005). GLOBOCAN 2005: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 7",https://gco.iarc.fr/,registry
C1168401,Squamous cell carcinoma of the head and neck,6.5,,incidence,520000,0.82,True,Head and Neck Neoplasms,Reporting cancer incidence. GLOBOCAN 2002/2005 data shows head and neck squamous cell carcinoma at ~6-7 per 100k globally. Squamous cell histology represents ~90% of head and neck cancers.,strong,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C1176475,Ductal Carcinoma,,,,,0.0,False,,"Umbrella term without organ specification. Ductal carcinomas occur in multiple organs (breast, pancreas, prostate, salivary glands) with vastly different incidence rates. Cannot provide meaningful aggregate estimate without anatomical specificity.",none,unknown,False,,,,
C1261473,Sarcoma,5.0,,incidence,400000,0.28,False,,"Aggregate BOTEC estimate summing major sarcoma categories: soft tissue sarcomas (~3.5 per 100k), bone sarcomas (~1 per 100k), Kaposi sarcoma (~0.5 per 100k) = ~5 per 100k. Heterogeneous group with varying biology and prognosis.",weak,moderate,False,2005,,,estimate
C1263846,Attention Deficit Hyperactivity Disorder,,5300,prevalence,424000000,0.78,False,,"ADHD is a chronic neurodevelopmental disorder measured by prevalence, not incidence. Global prevalence ~5.3% (5,300 per 100k) in school-age children based on meta-analyses circa 2005.",strong,moderate,False,2007,Polanczyk G et al. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164(6):942-8,https://pubmed.ncbi.nlm.nih.gov/17541055/,literature
C1264041,"von Willebrand Disease, Type 3",extremely rare,,incidence,extremely rare,0.45,True,von Willebrand Disease,Type 3 vWD is the rarest and most severe form (autosomal recessive). Incidence estimated at 0.1-0.5 per million population (0.0001-0.0005 per 100k) based on hemophilia treatment center registries.,moderate,low,False,,Mannucci PM. (2004). Treatment of von Willebrand's Disease. N Engl J Med. 351:683-694,https://pubmed.ncbi.nlm.nih.gov/15306670/,literature
C1265996,Large cell neuroendocrine carcinoma,0.75,,incidence,60000,0.52,True,Lung Cancer,"Large cell neuroendocrine carcinoma (LCNEC) represents approximately 2-3% of all lung cancers. Derived from global lung cancer incidence (~30 per 100k) × 0.025 = ~0.75 per 100k. Rare aggressive subtype, primarily pulmonary.",moderate,moderate,False,,Travis WD et al. (2004). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung. IARC Press,,literature
C1269683,Major Depressive Disorder,350,4300,both,28000000,0.82,False,,"MDD global incidence ~350 per 100k person-years, prevalence ~4.3% (4300 per 100k). DSM-defined condition with robust epidemiological data from WHO GBD and multiple cohort studies.",strong,moderate,True,2005,"Kessler RC et al. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 352:2515-2523",https://pubmed.ncbi.nlm.nih.gov/15958807/,literature
C1269955,Tumor Cell Invasion,,,,,0.0,False,,"Tumor cell invasion is a biological process/phenomenon, not a disease entity. It describes the invasive behavior of malignant tumor cells, not a specific diagnosable condition. Unmappable to incidence rates.",none,unknown,False,,,,
C1275217,Paget's disease of vulva,extremely rare,,incidence,extremely rare,0.35,True,Extramammary Paget's disease,"Reporting incidence (new cancer diagnoses). Extramammary Paget's of vulva is extremely rare, <0.01 per 100k women based on case series and registry data. Limited epidemiological data available.",weak,unknown,False,,,,
C1290886,Chronic Inflammatory Disorder,,,,,0.0,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Encompasses autoimmune diseases, inflammatory bowel disease, chronic infections, asthma, and numerous other disparate conditions with vastly different etiologies and epidemiology.",none,unknown,False,,,,
C1292753,Primary Effusion Lymphoma,extremely rare,,incidence,extremely rare,0.35,True,B-cell Non-Hodgkin Lymphoma,"Rare HHV-8-associated lymphoma, primarily in immunocompromised patients. Estimated <0.1 per 100k based on case series and HIV cohort studies. No systematic registry data.",weak,moderate,False,,,,
C1292769,Precursor B-cell lymphoblastic leukemia,1.0,,incidence,80000,0.88,True,Acute Lymphoblastic Leukemia,"B-cell ALL represents 75-80% of all ALL cases. Overall ALL incidence ~1.3 per 100k (all ages), therefore B-ALL ~1.0 per 100k. Most common childhood leukemia with excellent registry data from SEER and international pediatric oncology groups.",strong,low,True,2005,Howlader N et al. SEER Cancer Statistics Review 1975-2005,https://seer.cancer.gov/csr/1975_2005/,registry
C1302401,Adenoma of large intestine,,25000,prevalence,2000000000,0.65,False,,Reporting prevalence rather than incidence - colorectal adenomas are detected lesions found in ~25% of adults during screening colonoscopy (varies 15-40% by age/region). Prevalence more appropriate than incidence for screening-detected precancerous lesions.,moderate,moderate,False,,Lieberman DA et al. (2000). Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 343:162-168,https://pubmed.ncbi.nlm.nih.gov/10900274/,literature
C1306459,Primary malignant neoplasm,175.0,,incidence,14000000,0.25,False,Malignant Neoplasms,"Aggregate BOTEC estimate for primary cancers (excluding metastases). GLOBOCAN 2005 data shows ~175 per 100k globally for all primary malignancies. Umbrella term covering lung, breast, colorectal, prostate, stomach, liver, and all other primary cancer sites. Low confidence due to heterogeneity across cancer types.",weak,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1306460,Primary malignant neoplasm of lung,35.0,,incidence,2800000,0.88,True,Lung Neoplasms,Primary lung cancer incidence from GLOBOCAN 2005: ~35 per 100k globally (age-standardized rate). Excludes metastatic disease to lung. High confidence from cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1332199,Adult Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.35,True,Desmoplastic Small Round Cell Tumor,"Extremely rare sarcoma, adult-onset variant. Fewer than 200 cases reported in literature worldwide. Estimated <0.01 per 100k based on case report frequency.",weak,unknown,False,,,,
C1332201,Adult Diffuse Large B-Cell Lymphoma,4.5,,incidence,360000,0.78,True,Diffuse Large B-Cell Lymphoma,"Adult-specific DLBCL represents majority of DLBCL cases (median age 60-70 years). Incidence ~4.5 per 100k adults, slightly higher than general population estimate since pediatric DLBCL is rare.",strong,moderate,True,2005,"Morton LM et al. (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 107(1):265-276",https://pubmed.ncbi.nlm.nih.gov/16150940/,literature
C1332206,Adult Lymphoma,19.5,,incidence,1560000,0.85,True,Lymphoma,"Reporting incidence (new diagnoses) in adults. Combined Hodgkin lymphoma (~2.5 per 100k) and Non-Hodgkin lymphoma (~17 per 100k) for adults based on GLOBOCAN 2005 data, total approximately 19.5 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1332922,Cervical Squamous Intraepithelial Neoplasia,,400,prevalence,32000000,0.65,True,Cervical Intraepithelial Neoplasia,"CIN measured as prevalence in screened populations. Detection rate of CIN2+ approximately 400 per 100k women screened, based on cervical cancer screening program data. Squamous type represents majority of CIN cases.",moderate,high,False,,Wright TC et al. (2007). 2006 consensus guidelines for management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 197(4):340-345,https://pubmed.ncbi.nlm.nih.gov/17904955/,literature
C1332966,Childhood Desmoplastic Small Round Cell Tumor,extremely rare,,incidence,extremely rare,0.4,True,Intra-abdominal Sarcoma,"Extremely rare pediatric malignancy, <0.01 per 100k. Approximately 30-40 new cases reported globally per year based on case series literature.",weak,unknown,False,,"Gerald WL et al. (1998). Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 16(9):3028-36",https://pubmed.ncbi.nlm.nih.gov/9738572/,literature
C1332977,Childhood Leukemia,4.5,,incidence,360000,0.85,True,Leukemia,"Reporting incidence. Childhood leukemia (age 0-14) incidence ~4.5 per 100k children globally, with ALL comprising ~80% of cases. Well-documented in pediatric cancer registries.",strong,moderate,False,2005,Kaatsch P. (2010). Epidemiology of childhood cancer. Cancer Treat Rev. 36(4):277-285,https://pubmed.ncbi.nlm.nih.gov/20231056/,literature
C1332979,Childhood Lymphoma,1.8,,incidence,144000,0.82,True,Lymphoma,Reporting incidence (new diagnoses) in children aged 0-19. Pediatric lymphomas (Hodgkin + Non-Hodgkin) incidence approximately 1.8 per 100k children globally based on SEER and international cancer registry data from mid-2000s.,strong,moderate,False,2005,"Linabery AM, Ross JA (2008). Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 113(9):2575-96",https://pubmed.ncbi.nlm.nih.gov/18837040/,literature
C1332986,Childhood Osteosarcoma,0.3,,incidence,24000,0.78,True,Osteosarcoma,"Osteosarcoma is the most common primary bone malignancy in children and adolescents. Incidence approximately 3-4 per million children per year, or ~0.3 per 100k of pediatric population.",strong,low,False,2006,Mirabello L et al. (2009). Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer. 115(7):1531-1543,https://pubmed.ncbi.nlm.nih.gov/19197972/,literature
C1334665,Mediastinal Lymphoma,1.5,,incidence,120000,0.58,True,Lymphoma,Mediastinal lymphomas include primary mediastinal B-cell lymphoma (~0.4 per 100k) and Hodgkin lymphoma with mediastinal involvement (~1.1 per 100k). Combined estimate ~1.5 per 100k based on lymphoma registry data.,moderate,moderate,False,2005,Lones MA et al. (2000). Primary mediastinal B-cell lymphoma: epidemiology and clinical features. Curr Opin Oncol. 12(5):462-8,https://pubmed.ncbi.nlm.nih.gov/10975555/,literature
C1334953,Neuroblastic tumors,0.21,,incidence,16800,0.75,True,Peripheral Nervous System Neoplasms,"Reporting incidence of new cases. Neuroblastic tumors (primarily neuroblastoma) occur mainly in children with incidence of ~10.5 per million children under 15, translating to ~0.21 per 100k total population. Data from international cancer registries including SEER.",strong,low,False,2005,"Ries LAG et al. (2007). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute",https://seer.cancer.gov/,registry
C1335475,Primary Carcinoma,,,,,0.0,False,,"Umbrella term too broad to estimate meaningfully. Primary carcinoma without organ specification includes lung, breast, colon, prostate, etc. with vastly different incidence rates. Requires anatomical specification.",none,unknown,False,,,,
C1336716,testicular embryonal carcinoma and teratoma,1.2,,incidence,96000,0.55,True,Testicular Germ Cell Tumor,"Mixed germ cell tumor representing subset of testicular cancer. Overall testicular cancer incidence ~6 per 100k men (3 per 100k overall). Mixed GCTs comprise ~40% of cases, estimating ~1.2 per 100k overall population.",moderate,moderate,False,,,,
C1378703,Renal carcinoma,6.8,,incidence,544000,0.88,True,Malignant neoplasm of kidney,"Reporting incidence of renal cell carcinoma (RCC), which comprises ~90% of kidney cancers. GLOBOCAN 2005 data shows global kidney cancer incidence ~7.6 per 100k; RCC subset ~6.8 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1391732,Cancer cachexia,110,,incidence,8800000,0.55,False,Cachexia,"Cancer-associated cachexia syndrome (weight loss, muscle wasting) develops in 50-80% of cancer patients depending on tumor type. Global cancer incidence ~200 per 100k, with approximately 50-60% developing cachexia yields ~110 per 100k. Higher rates in pancreatic, gastric, and lung cancers.",moderate,moderate,False,,Tisdale MJ. (2002). Cachexia in cancer patients. Nat Rev Cancer. 2(11):862-71,https://pubmed.ncbi.nlm.nih.gov/12415256/,literature
C1449563,"Cardiomyopathy, Familial Idiopathic",2.5,,incidence,200000,0.55,True,Dilated Cardiomyopathy,Familial (genetic) forms account for ~30-50% of dilated cardiomyopathy cases. Estimated incidence ~2-3 per 100k based on familial proportion of DCM. Lower confidence due to limited specific epidemiological data for familial subset.,moderate,moderate,False,,Mestroni L et al. (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 34(1):181-90,https://pubmed.ncbi.nlm.nih.gov/10400009/,literature
C1458155,Mammary Neoplasms,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate: includes benign tumors (fibroadenomas, very common) and malignant breast cancers with vastly different incidence rates and clinical significance.",none,unknown,False,,,,
C1510885,Angiogenic Switch,,,,,0.0,False,,"Not a disease entity - angiogenic switch is a biological process/mechanism in cancer development where tumors acquire the ability to stimulate new blood vessel growth. This is a molecular/cellular process descriptor, not a mappable disease condition.",none,unknown,False,,,,
C1511306,Breast Diffuse Large B-Cell Lymphoma,0.05,,incidence,4000,0.45,True,Diffuse Large B-Cell Lymphoma,"Primary breast lymphoma is extremely rare, accounting for <1% of breast malignancies. DLBCL is the most common histology. Estimated at ~0.05 per 100k based on case series data. Low confidence due to rarity and limited population-based studies.",weak,unknown,False,,,,
C1511789,Desmoplastic,,,,,0.0,False,,Unmappable - 'Desmoplastic' is a pathological descriptor (fibrous tissue formation) rather than a disease entity. Cannot estimate incidence for a descriptive term.,none,unknown,False,,,,
C1512409,Hepatocarcinogenesis,,,,,0.0,False,,"This is a biological process term (the process of liver cancer development), not a specific disease entity. Unmappable as it describes carcinogenesis rather than a diagnosable condition.",none,unknown,False,,,,
C1512433,Cervical high grade squamous intraepithelial lesion,150,,incidence,12000000,0.72,True,Cervical Intraepithelial Neoplasia,"HSIL (CIN 2/3) detection rate from cervical screening programs. Global average ~150 per 100k women screened annually, based on WHO cervical cancer screening data. Corresponds to CIN 2 and CIN 3 combined. Varies significantly by screening coverage and HPV prevalence.",strong,high,False,2005,WHO/ICO Information Centre on HPV and Cervical Cancer (2005),https://www.who.int/reproductivehealth/publications/cancers/9241546743/en/,registry
C1519346,Skin Carcinogenesis,,,,,0.0,False,,"Process term describing cancer development, not a specific disease. Actual skin cancers (basal cell, squamous cell, melanoma) each have distinct incidence rates.",none,unknown,False,,,,
C1519670,Tumor Angiogenesis,,,,,0.0,False,,"Tumor angiogenesis is a biological process (formation of new blood vessels in tumors), not a disease entity. It is a characteristic feature of tumor growth and progression, not a mappable disease with incidence. Unmappable as a process descriptor.",none,unknown,False,,,,
C1527231,Adrenomyeloneuropathy,0.3,,incidence,24000,0.55,True,X-linked Adrenoleukodystrophy,"Adult-onset form of X-linked adrenoleukodystrophy. Overall X-ALD incidence ~1 in 17,000 males (0.6 per 100k), AMN represents approximately 50% of cases. Estimated at ~0.3 per 100k. Limited population-based registry data.",moderate,low,False,,"Bezman L et al. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 49(4):512-7",https://pubmed.ncbi.nlm.nih.gov/11310629/,literature
C1527349,Ductal Breast Carcinoma,18.0,,incidence,1440000,0.82,True,Breast Cancer,"Invasive ductal carcinoma (IDC) accounts for ~70-80% of breast cancers. Global breast cancer incidence 2005 was ~50 per 100k women (GLOBOCAN), translating to ~25 per 100k overall population. IDC represents ~72% of cases, yielding ~18 per 100k.",strong,moderate,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C1535926,Neurodevelopmental Disorders,800,,incidence,64000000,0.25,False,,"Aggregate BOTEC estimate summing major neurodevelopmental conditions detected in childhood: autism spectrum disorder (~100 per 100k births), intellectual disability (~150 per 100k births), ADHD (~400 per 100k children), learning disorders (~150 per 100k). Total ~800 per 100k. Low confidence due to heterogeneous conditions, overlap, and mix of incidence/prevalence metrics.",weak,moderate,False,,,,estimate
C1535939,Pneumocystis jiroveci pneumonia,2.5,,incidence,200000,0.55,True,Fungal Pneumonia,"Opportunistic infection primarily in immunocompromised patients (HIV, transplant, chemotherapy). Global incidence ~2-3 per 100k (2005), but highly concentrated in HIV-positive populations and regions with limited HAART access. Significant underreporting in developing countries.",moderate,high,False,2005,Morris A et al. (2004). Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 10(10):1713-20,https://pubmed.ncbi.nlm.nih.gov/15504255/,literature
C1536148,Chocolate cyst of ovary,,600,prevalence,48000000,0.62,True,Endometrioma,Chocolate cyst is a descriptive term for ovarian endometrioma (blood-filled cyst). Same entity as endometrioma but specifically ovarian. Prevalence slightly lower than general endometrioma as it specifies ovarian location (~600 per 100k).,moderate,moderate,False,,Giudice LC et al. (2004). Endometriosis. Lancet. 364(9447):1789-1799,https://pubmed.ncbi.nlm.nih.gov/15541453/,literature
C1571983,Involutional paraphrenia,0.5,,incidence,40000,0.35,True,Late-onset psychotic disorders,Historical term for late-onset paranoid psychosis (typically age >60). Estimated ~0.5 per 100k based on late-onset schizophrenia and delusional disorder incidence in elderly populations. Low confidence due to outdated diagnostic category and limited specific epidemiological data.,weak,unknown,False,,,,
C1571984,"Psychosis, Involutional",0.5,,incidence,40000,0.35,True,Late-onset psychotic disorders,Historical term for psychotic disorders with onset during involutional period (middle to late life). Estimated ~0.5 per 100k based on late-onset psychosis incidence. Low confidence due to obsolete diagnostic category and lack of specific epidemiological data.,weak,unknown,False,,,,
C1608408,Malignant transformation,,,,,0.0,False,,"Unmappable - this is a biological process descriptor, not a specific disease entity. Refers to the process of normal or benign cells becoming cancerous, which occurs across hundreds of different cancer types. Cannot assign meaningful incidence without specifying the tissue/organ system and disease context.",none,unknown,False,,,,
C1611743,Familial (FPAH),extremely rare,,incidence,extremely rare,0.45,True,Pulmonary Arterial Hypertension,Familial PAH (FPAH) is an extremely rare genetic form of pulmonary arterial hypertension. Estimated at <0.1 per 100k based on registry data showing FPAH represents ~6% of idiopathic PAH cases which itself is ~1-2 per million.,moderate,low,False,,Humbert M et al. (2006). Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 173(9):1023-30,https://pubmed.ncbi.nlm.nih.gov/16456139/,literature
C1691215,Penile hypospadias,350,,incidence,28000000,0.72,True,Hypospadias,"Reporting incidence at birth. Penile hypospadias (distal/glandular) accounts for ~70% of all hypospadias cases. Global hypospadias rate ~500 per 100k male births, so penile type ~350 per 100k male births.",moderate,moderate,False,,Baskin LS et al. (2018). Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 109:1175-1183,https://pubmed.ncbi.nlm.nih.gov/11713001/,literature
C1704251,Breast Lymphoma,0.5,,incidence,40000,0.65,True,Non-Hodgkin Lymphoma,"Primary breast lymphoma is rare, representing <1% of breast malignancies and ~2% of extranodal lymphomas. Estimated at ~0.5 per 100k women based on cancer registry data.",moderate,low,False,,"Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705-12",https://pubmed.ncbi.nlm.nih.gov/5032234/,literature
C1704272,Benign Prostatic Hyperplasia,,6500,prevalence,520000000,0.78,False,,"BPH is a chronic progressive condition best measured by prevalence. Age-dependent (50% of men in 50s, 80% in 80s). Global prevalence ~13% of adult men, or ~6,500 per 100k total population.",strong,low,False,2005,Roehrborn CG (2005). Benign prostatic hyperplasia: an overview. Rev Urol. 7(Suppl 9):S3-S14,https://pubmed.ncbi.nlm.nih.gov/16985902/,literature
C1704423,Milroy Disease,extremely rare,,incidence,extremely rare,0.35,True,Primary Lymphedema,"Rare congenital genetic disorder causing lymphedema from birth. Estimated at 1 in 6,000 to 1 in 300,000 births, approximately 0.3-1.7 per 100k births. Limited epidemiological data available.",weak,unknown,False,,,,
C1720830,Painful Bladder Syndrome,,197,prevalence,15760000,0.58,False,,"Interstitial cystitis/painful bladder syndrome measured as prevalence. Estimated ~197 per 100k (predominantly women, 9:1 ratio) based on early 2000s epidemiological studies. Wide diagnostic variability affects estimates. Chronic condition, incidence poorly defined.",moderate,moderate,False,2005,Clemens JQ et al. (2005). Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 173(1):98-102,https://pubmed.ncbi.nlm.nih.gov/15592041/,literature
C1720983,Channelopathies,,,,,0.0,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes diverse ion channel disorders across multiple organ systems: cardiac (Long QT, Brugada), neurologic (some epilepsies, migraines), pulmonary (cystic fibrosis), muscular (myotonias, periodic paralyses), and renal channelopathies. These have vastly different incidence rates, pathophysiology, and clinical significance. Aggregate estimate not useful.",none,unknown,False,,,,
C1833683,"Nephrolithiasis, Calcium Oxalate",120,,incidence,9600000,0.72,True,Nephrolithiasis,"Calcium oxalate stones comprise ~80% of all kidney stones. Total kidney stone incidence approximately 150 per 100k person-years in developed countries, so calcium oxalate subset ~120 per 100k.",moderate,moderate,False,2005,Stamatelou KK et al. (2003). Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63(5):1817-1823,https://pubmed.ncbi.nlm.nih.gov/12675858/,literature
C1836122,"SARCOIDOSIS, EARLY-ONSET",1.5,,incidence,120000,0.55,True,Sarcoidosis,"Reporting incidence of early-onset sarcoidosis (pediatric/young adult). Overall sarcoidosis incidence is 10-20 per 100k in high-incidence populations; early-onset represents approximately 10-15% of cases, estimated at 1-2 per 100k. Limited specific epidemiological data for early-onset subtype.",moderate,high,False,,"Henke CE et al. (1986). The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study. Am J Epidemiol. 123(5):840-845",https://pubmed.ncbi.nlm.nih.gov/3962966/,literature
C1839839,MAJOR AFFECTIVE DISORDER 2,extremely rare,,,extremely rare,0.25,True,Major Affective Disorders,Genetic variant designation (likely OMIM-based) for familial mood disorder. Extremely rare monogenic form. No population-based incidence data; estimated <0.01 per 100k based on genetic case reports.,weak,unknown,False,,,,
C1852197,MAJOR AFFECTIVE DISORDER 1,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD1) on chromosome 18q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C1859405,Bowen-Conradi syndrome,extremely rare,,incidence,extremely rare,0.35,False,,"Extremely rare autosomal recessive disorder, primarily in Hutterite populations. <0.01 per 100k globally based on case report literature. Fewer than 100 cases reported worldwide.",weak,high,False,,,,
C1861172,Venous Thromboembolism,117.0,,incidence,9360000,0.82,False,,VTE encompasses DVT and PE. Incidence data from multiple population-based studies shows ~100-200 per 100k in Western populations. Using mid-range estimate of 117 per 100k based on pooled epidemiological data circa 2005.,strong,moderate,False,2006,Heit JA et al. (2005). The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 21(1):23-29,https://pubmed.ncbi.nlm.nih.gov/16475038/,literature
C1861305,TARSAL-CARPAL COALITION SYNDROME,extremely rare,,incidence,extremely rare,0.25,False,,Extremely rare genetic syndrome characterized by fusion of carpal and tarsal bones. <100 cases reported in medical literature worldwide. Estimated <0.01 per 100k based on case report frequency only.,weak,unknown,False,,,,
C1864040,Cerebral Cavernous Malformations 3,extremely rare,,incidence,extremely rare,0.3,True,Cerebral Cavernous Malformations,"CCM3 is a specific genetic subtype caused by PDCD10 gene mutations, one of three CCM genes (CCM1/KRIT1, CCM2, CCM3/PDCD10). CCM3 represents ~10-15% of familial CCM cases. With overall familial CCM birth incidence <0.1 per 100k, CCM3 incidence is <0.01 per 100k. Limited population-based data for specific genetic subtypes.",weak,unknown,False,,,,
C1867441,Pterygium Of Conjunctiva And Cornea,8.0,,incidence,640000,0.52,False,Pterygium,"Pterygium of conjunctiva and cornea (full anatomical description of same condition as C0033999 and C4520843). Incidence ~8 per 100k globally with extreme geographic variation (UV-dependent, 0.3-29% prevalence by latitude).",moderate,high,False,,,,
C1868081,Juvenile Polyposis Coli,extremely rare,,incidence,extremely rare,0.35,True,Juvenile Polyposis Syndrome,"Extremely rare hereditary condition, subset of juvenile polyposis syndrome affecting primarily the colon. Estimated <0.1 per 100k births based on case reports and genetic registry data. Limited systematic epidemiological studies.",weak,unknown,False,,,,
C1868681,DYSTONIA 12,extremely rare,,incidence,extremely rare,0.3,True,Dystonia,DYT12 (rapid-onset dystonia-parkinsonism) is an extremely rare autosomal dominant genetic disorder caused by ATP1A3 mutations. Estimated <0.01 per 100k based on case report frequency. Only dozens of families reported worldwide.,weak,unknown,False,,,,
C1868683,"B-CELL MALIGNANCY, LOW-GRADE",3.5,,incidence,280000,0.28,False,,"Aggregate BOTEC estimate summing major low-grade B-cell malignancies: CLL (~2.0), follicular lymphoma (~1.0), MALT/marginal zone lymphomas (~0.5) = ~3.5 per 100k. Heterogeneous umbrella term with variable prognosis.",weak,moderate,False,2005,GLOBOCAN 2005 NHL data (aggregated subtypes),https://gco.iarc.fr/,registry
C1868938,End stage cardiac failure,35,,incidence,2800000,0.55,True,Heart failure,End-stage heart failure represents advanced disease (NYHA Class IV). Estimated at ~15-20% of incident heart failure cases progress to end-stage. Approximate incidence ~35 per 100k person-years. Limited population-based data for this specific stage.,moderate,moderate,False,,,,
C1955634,Kaposi's sarcoma-associated herpesvirus infection,2.5,,incidence,200000,0.65,False,,"Reporting Kaposi's sarcoma incidence as proxy for clinically significant HHV-8 infection. GLOBOCAN 2005 data shows ~2.5 per 100k globally, with high geographic variation (much higher in sub-Saharan Africa due to HIV co-infection).",moderate,high,True,2005,Ferlay J et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-2917,https://pubmed.ncbi.nlm.nih.gov/21351269/,registry
C1956346,Coronary Artery Disease,268,3700,both,21440000,0.78,True,Atherosclerosis,"CAD is atherosclerosis of coronary arteries. Reporting incidence of ~268 per 100k based on WHO Global Burden of Disease 2005 data for ischemic heart disease events. Prevalence ~3.7% (3,700 per 100k) in adults. Subtype of atherosclerosis with strong epidemiological data.",strong,high,True,2005,WHO Global Burden of Disease Study 2005,https://www.who.int/healthinfo/global_burden_disease/,registry
C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.35,,incidence,28000,0.58,True,Acute Lymphoblastic Leukemia,"T-cell immunophenotype represents ~15-25% of ALL/LBL cases. Overall ALL incidence ~1.8 per 100k, T-cell subset estimated at ~0.35 per 100k. Moderate confidence due to limited immunophenotype-specific registry data for 2005.",moderate,low,False,,Pui CH et al. (2008). Acute lymphoblastic leukemia. N Engl J Med. 350:1535-1548,https://pubmed.ncbi.nlm.nih.gov/15071128/,literature
C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,1.5,,incidence,120000,0.85,True,Leukemia,Acute lymphoblastic leukemia (ALL) incidence ~1.5 per 100k globally. Well-documented in cancer registries with consistent reporting across populations.,strong,low,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C1963943,Atherothrombosis,,,,,0.0,False,,"Pathophysiological process descriptor rather than discrete disease entity. Atherothrombosis describes the mechanism underlying MI, stroke, and peripheral arterial disease, not a separate diagnosis. Would create complete overlap with these specific conditions.",none,unknown,False,,,,
C1970943,MAJOR AFFECTIVE DISORDER 4,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD4) on chromosome 5q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C1970945,MAJOR AFFECTIVE DISORDER 6,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD6) on chromosome 15q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial mood disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2239176,Liver carcinoma,10.8,,incidence,864000,0.87,True,Liver Cancer,Hepatocellular carcinoma (HCC) incidence from GLOBOCAN 2002 data (closest to 2005): ~10.8 per 100k globally. Geographic variation is substantial: <2 per 100k in North America/Europe versus >20 per 100k in East Asia and sub-Saharan Africa due to hepatitis B and C prevalence.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C2350344,Chronic Lung Injury,,,,,0.0,False,,"Umbrella term too heterogeneous and vague to estimate meaningfully. Could encompass COPD, pulmonary fibrosis, chronic ARDS sequelae, occupational lung disease, and many other conditions with vastly different etiologies, prevalences, and clinical significance.",none,unknown,False,,,,
C2362324,Pediatric Obesity,,3200,prevalence,256000000,0.78,True,Obesity,"Chronic condition measured as prevalence. WHO data from 2005 shows approximately 3.2% of children globally were obese (3,200 per 100k). Prevalence is the appropriate metric for this chronic condition.",strong,high,True,2005,de Onis M et al. (2010). Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 92(5):1257-64,https://pubmed.ncbi.nlm.nih.gov/20861173/,literature
C2363741,HIV-1 infection,43.0,,incidence,3440000,0.88,True,HIV infection,"HIV-1 is the most common HIV type globally. UNAIDS 2005 report estimated 2.8 million new HIV infections globally, approximately 43 per 100k person-years. High geographic variation with Sub-Saharan Africa having much higher rates.",strong,high,True,2005,UNAIDS/WHO AIDS Epidemic Update 2005,https://data.unaids.org/publications/irc-pub06/epi_update2005_en.pdf,registry
C2697636,Hyperdiploid B Acute Lymphoblastic Leukemia,1.2,,incidence,96000,0.65,True,B-cell Acute Lymphoblastic Leukemia,"Reporting incidence of new diagnoses. Hyperdiploid B-ALL represents ~25-30% of childhood B-ALL cases. With pediatric ALL incidence ~4 per 100k children and hyperdiploid being 25-30% of B-ALL cases, estimated ~1.2 per 100k overall population.",moderate,low,False,,Pui CH et al. (2004). Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 22(15):2902-2913,https://pubmed.ncbi.nlm.nih.gov/15254062/,literature
C2700438,MAJOR AFFECTIVE DISORDER 7,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD7) on chromosome 1q, not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2700439,MAJOR AFFECTIVE DISORDER 8,,,,,0.0,True,Bipolar Disorder,"Genetic locus (MAFD8), not a distinct clinical entity with separate epidemiological data. Represents chromosomal linkage for familial bipolar disorder susceptibility, not measurable as independent incidence.",none,unknown,False,,,,
C2700440,MAJOR AFFECTIVE DISORDER 9,extremely rare,,,extremely rare,0.25,True,Major Affective Disorders,"Genetic variant designation for familial mood disorder, likely another rare monogenic form. No systematic epidemiological data; estimated <0.01 per 100k based on genetic literature.",weak,unknown,False,,,,
C2711227,Steatohepatitis,,3000.0,prevalence,240000000,0.7,False,,"Encompasses NASH and alcoholic steatohepatitis. Chronic liver condition measured by prevalence rather than incidence. Global NASH prevalence circa 2005 estimated at 2-5% of adults, approximately 3,000 per 100k (3%). Incidence data poorly documented.",moderate,high,False,2005,Browning JD et al. (2004). Prevalence of hepatic steatosis in an urban population. Hepatology. 40(6):1387-1395,https://pubmed.ncbi.nlm.nih.gov/15565570/,literature
C2717836,Steroid Sulfatase Deficiency Disease,0.3,,incidence,24000,0.68,False,,"Steroid sulfatase deficiency causes X-linked ichthyosis. Same epidemiology as X-linked ichthyosis with birth prevalence 1 in 2,000-6,000 males, converting to ~0.3 per 100k person-years incidence.",moderate,low,False,,Orphanet and genetic disease registries,,registry
C2745900,Promyelocytic leukemia,0.15,,incidence,12000,0.68,True,Acute myeloid leukemia,"Reporting incidence at ~0.15 per 100k person-years. Acute promyelocytic leukemia (APL) represents 10-15% of AML cases. Global AML incidence ~1-1.5 per 100k, making APL ~0.1-0.2 per 100k based on cancer registry data.",strong,moderate,False,,Lehmann S et al. (2011). Continuing improvement in survival in acute promyelocytic leukemia. Blood. 118(11):e1-9,https://pubmed.ncbi.nlm.nih.gov/21768301/,literature
C2749757,BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1,extremely rare,,incidence,extremely rare,0.35,True,Bronchiectasis,Rare genetic form of bronchiectasis associated with SCNN1B gene mutations. Specific incidence unknown but estimated <0.1 per 100k based on rarity in genetic databases and case report frequency.,weak,unknown,False,,,,
C2751310,"Hyperuricemic Nephropathy, Familial Juvenile 2",extremely rare,,incidence,extremely rare,0.3,True,Familial Juvenile Hyperuricemic Nephropathy,Extremely rare autosomal dominant disorder with juvenile-onset hyperuricemia and progressive renal failure. Caused by UMOD gene mutations. <0.01 per 100k based on genetic registry data and case reports.,weak,unknown,False,,Hart TC et al. (2002). Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 39(12):882-892,https://pubmed.ncbi.nlm.nih.gov/12471200/,literature
C2751492,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",extremely rare,,incidence,extremely rare,0.68,True,Hereditary Amyloidosis,"Hereditary transthyretin amyloidosis (ATTRv or familial amyloid polyneuropathy) is extremely rare, <0.1 per 100k globally. Higher in endemic areas (Portugal, Sweden, Japan) due to founder mutations. Incidence of symptomatic disease estimated <0.01 per 100k in non-endemic populations.",moderate,high,False,,"Schmidt HH et al. (2003). Roswell Park Cancer Institute, hereditary amyloidosis review. Amyloid. 10(Suppl 1):85-93",,literature
C2919945,Cavernous Hemangioma of Brain,,400,prevalence,32000000,0.7,False,,"Cerebral cavernous malformations (CCMs) are better characterized by prevalence than incidence, as they are congenital/developmental vascular malformations often remaining asymptomatic. MRI and autopsy studies show prevalence of 0.4-0.5% of population (~400 per 100k). Most are sporadic (80%) and discovered incidentally. Annual symptomatic presentation rate much lower (~0.5 per 100k), but total prevalence is the more meaningful epidemiological metric.",strong,low,False,,Zabramski JM et al. (1994). The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 80(3):422-432,https://pubmed.ncbi.nlm.nih.gov/8113854/,literature
C2931263,Familial cerebral cavernous malformation,extremely rare,80,prevalence,6400000,0.5,True,Cerebral Cavernous Malformations,"Familial CCM represents ~20% of all CCM cases (autosomal dominant inheritance with mutations in KRIT1, CCM2, or PDCD10 genes). With total CCM prevalence ~400 per 100k, familial cases estimated at ~80 per 100k. Birth incidence would be <0.05 per 100k. Prevalence is more appropriate metric as these are congenital malformations with variable age of symptom onset. Higher prevalence in Hispanic populations (New Mexico founder effect).",moderate,moderate,False,,Akers A et al. (2017). Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations. Neurosurgery. 80(5):665-680,https://pubmed.ncbi.nlm.nih.gov/28327981/,literature
C2931367,"Thyroid cancer, follicular",0.7,,incidence,56000,0.75,True,Thyroid Carcinoma,"Follicular thyroid carcinoma is a specific histological subtype comprising ~10-15% of all thyroid cancers. Global thyroid cancer incidence ~5 per 100k (GLOBOCAN 2005), so follicular subtype ~0.7 per 100k.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC) - thyroid cancer data with subtype distribution from SEER,https://gco.iarc.fr/,registry
C2931618,Gestational trophoblastic disease,3.2,,incidence,256000,0.55,False,,"Umbrella term including complete mole, partial mole, invasive mole, and choriocarcinoma. Global incidence approximately 1-2 per 1000 pregnancies (higher in Asia, lower in Western countries). Estimated at ~3.2 per 100k person-years based on pregnancy rates and molar pregnancy frequency.",moderate,high,False,,"Lurain JR. (2010). Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 203(6):531-539",https://pubmed.ncbi.nlm.nih.gov/20728069/,literature
C2931822,Nasopharyngeal carcinoma,1.2,,incidence,96000,0.85,True,Head and Neck Cancer,Nasopharyngeal carcinoma global incidence from GLOBOCAN 2005: ~1.2 per 100k. Extreme geographic variation: endemic in Southern China/Southeast Asia (20-30 per 100k) but <1 per 100k in most regions due to EBV and genetic factors.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C2936858,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,0.14,,incidence,11200,0.82,True,Congenital Adrenal Hyperplasia,"Classic 21-hydroxylase deficiency CAH occurs in ~1 per 15,000 births globally. With crude birth rate of ~20 per 1,000 population, this translates to ~0.14 per 100k person-years.",strong,moderate,False,,Speiser PW et al. (2010). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95(9):4133-60,https://pubmed.ncbi.nlm.nih.gov/20823466/,literature
C2939419,Secondary Neoplasm,,,,,0.0,False,,Umbrella term for all metastatic cancers to any site from any primary cancer. Too heterogeneous to estimate meaningfully - encompasses metastases from hundreds of primary cancer types to dozens of organs with vastly different incidence rates and clinical significance.,none,high,False,,,,
C2960064,Low grade dysplastic nodule,2.5,,incidence,200000,0.35,True,Hepatic dysplastic nodule,"Histopathological finding in cirrhotic livers, not a traditional disease entity. Estimated at ~20-30% of HCC cases (HCC ~12 per 100k), suggesting ~2.5 per 100k. Low confidence due to lack of population-based surveillance and unclear clinical significance.",weak,high,False,,,,
C2960065,High grade dysplastic nodule,1.8,,incidence,144000,0.32,True,Hepatic dysplastic nodule,"Pre-malignant liver lesion in cirrhotic patients, direct precursor to HCC. Less common than low-grade dysplastic nodules. Estimated at ~15% of HCC incidence (~1.8 per 100k). Very low confidence due to lack of population surveillance and detection bias.",weak,high,False,,,,
C2986703,Overgrowth Syndrome,2.0,,incidence,160000,0.28,False,,"Aggregate BOTEC estimate summing major overgrowth syndromes: Beckwith-Wiedemann (~1.0), Sotos (~0.5), Simpson-Golabi-Behmel (~0.2), Weaver (~0.1), Proteus (extremely rare), others (~0.2) = ~2 per 100k births. Heterogeneous group with varying severity.",weak,moderate,False,,,,estimate
C3151190,RETINITIS PIGMENTOSA 48,extremely rare,,incidence,extremely rare,0.35,True,Retinitis Pigmentosa,"RP48 is an extremely rare genetic subtype caused by specific mutations. While RP overall affects ~1 in 4000 (25 per 100k prevalence), type 48 represents <1% of RP cases. Estimated <0.01 per 100k based on genetic case reports.",weak,unknown,False,,,,
C3250443,MYOTONIC DYSTROPHY 1,,8.0,prevalence,640000,0.75,True,Myotonic Dystrophy,Genetic disorder measured by prevalence. DM1 prevalence approximately 8 per 100k based on population studies. Most common adult-onset muscular dystrophy. Type 1 (CTG expansion) is more common than Type 2.,strong,moderate,False,,Theadom A et al. (2014). Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology. 43(3-4):259-68,https://pubmed.ncbi.nlm.nih.gov/25532075/,literature
C3266262,Multiple Chronic Conditions,,25000,prevalence,2000000000,0.35,False,,"This is a prevalence-based concept (having 2+ chronic conditions simultaneously), not an incident disease. Estimated ~25% of global adults have multiple chronic conditions based on WHO 2005 data, but definition varies widely across studies.",weak,high,False,,,,
C3280216,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3",extremely rare,,incidence,extremely rare,0.3,True,Familial Juvenile Hyperuricemic Nephropathy,Extremely rare autosomal dominant tubulointerstitial kidney disease caused by specific genetic mutations. <0.01 per 100k based on case report frequency and genetic databases. Specific genetic subtype (FJHN3).,weak,unknown,False,,,,
C3463824,Myelodysplastic Syndrome,4.0,,incidence,320000,0.82,False,,"MDS global incidence ~4 per 100k overall population, but strongly age-dependent (15-50 per 100k in adults >70). Well-documented in cancer registries including SEER and European registries.",strong,moderate,False,2005,Ma X et al. (2007). Epidemiology of myelodysplastic syndromes. Am J Med. 120(7 Suppl 1):S2-10,https://pubmed.ncbi.nlm.nih.gov/17602924/,literature
C3469186,"HEMOCHROMATOSIS, TYPE 1",2.5,,incidence,200000,0.65,True,Hereditary Hemochromatosis,"HFE-related hereditary hemochromatosis (Type 1), most common form. Clinical diagnosis incidence ~2-3 per 100k despite higher genetic prevalence. Based on population screening studies.",moderate,moderate,False,2005,Adams PC et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 352:1769-78,https://pubmed.ncbi.nlm.nih.gov/15858186/,literature
C3495559,Juvenile Arthritis,10.0,,incidence,800000,0.65,False,,"Juvenile arthritis (synonym for juvenile idiopathic arthritis) incidence approximately 10 per 100k children annually. Moderate confidence from pediatric rheumatology studies, though population-based data varies by diagnostic criteria used.",moderate,moderate,False,,Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,https://pubmed.ncbi.nlm.nih.gov/12951861/,literature
C3495917,Advanced breast cancer,4.2,,incidence,336000,0.65,True,Breast Cancer,"Advanced/metastatic breast cancer at diagnosis represents ~5-10% of total breast cancer incidence. Global breast cancer incidence ~44 per 100k (2005), advanced stage estimated at ~4.2 per 100k. Moderate confidence due to staging definition variability.",moderate,moderate,True,2005,Estimated from GLOBOCAN 2005 breast cancer data with stage distribution from SEER,https://gco.iarc.fr/,estimate
C3495919,Enthesitis-Related Arthritis,0.8,,incidence,64000,0.55,True,Juvenile Idiopathic Arthritis,"Reporting incidence of new diagnoses in pediatric population. ERA represents approximately 15-20% of JIA cases, with overall JIA incidence of 4-5 per 100k children. Estimated at ~0.8 per 100k children globally. Moderate confidence due to limited population-based epidemiological studies.",moderate,moderate,False,,Saurenmann RK et al. (2007). Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 56(6):1974-1984,https://pubmed.ncbi.nlm.nih.gov/17530723/,literature
C3711374,Nonsyndromic Deafness,2.8,,incidence,224000,0.65,True,Congenital deafness,Nonsyndromic hearing loss comprises ~70% of hereditary congenital deafness. Estimated at ~2.8 per 100k person-years based on proportion of congenital cases.,moderate,moderate,False,,Morton CC et al. (2006). Newborn hearing screening--a silent revolution. N Engl J Med. 354(20):2151-2164,https://pubmed.ncbi.nlm.nih.gov/16707752/,literature
C3714619,Insulin resistance syndrome,,22000,prevalence,1760000000,0.8,False,,"Also known as metabolic syndrome. Chronic condition measured by prevalence. Global prevalence approximately 20-25% (22,000 per 100k) in adults circa 2005, varying by diagnostic criteria and population. Well-documented syndrome with strong epidemiological data.",strong,high,True,2005,Hu G et al. (2004). Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 164(10):1066-76,https://pubmed.ncbi.nlm.nih.gov/15159263/,literature
C3714756,Intellectual Disability,,1500,prevalence,120000000,0.65,False,,Modern terminology for developmental cognitive impairment. Prevalence metric used as this is a lifelong condition typically diagnosed in childhood. Global prevalence ~1-2% (1500 per 100k) based on meta-analyses. Moderate confidence due to acceptable prevalence data but diagnostic criteria variation across regions.,moderate,moderate,False,,Maulik PK et al. (2011). Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 32(2):419-436,https://pubmed.ncbi.nlm.nih.gov/21236634/,literature
C3714757,Juvenile Rheumatoid Arthritis,10.0,,incidence,800000,0.65,True,Rheumatoid Arthritis,Juvenile idiopathic arthritis (JIA) incidence approximately 10 per 100k children annually based on pediatric rheumatology literature. Moderate confidence due to varying diagnostic criteria and limited population-based registries.,moderate,moderate,False,,Manners PJ et al. (2003). Epidemiology of juvenile chronic arthritis. Rheum Dis Clin North Am. 29(3):431-446,https://pubmed.ncbi.nlm.nih.gov/12951861/,literature
C3805278,Extrahepatic Cholangiocarcinoma,1.2,,incidence,96000,0.68,True,Cholangiocarcinoma,Extrahepatic bile duct cancer incidence ~1.2 per 100k from cancer registry data. Comprises perihilar and distal bile duct tumors. Higher rates in Southeast Asia due to liver fluke exposure.,moderate,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C3806153,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1",extremely rare,,incidence,extremely rare,0.3,True,Hypochromic Microcytic Anemia,"Reporting incidence of this extremely rare genetic disorder. Very few cases documented in medical literature, estimated <0.01 per 100k. Limited systematic epidemiological studies available for this specific genetic subtype.",weak,unknown,False,,,,
C3854222,Human immunodeficiency virus (HIV) II infection category B1,0.05,,incidence,4000,0.35,True,HIV-2 infection,"HIV-2 Category B1 is a very specific CDC classification stage. HIV-2 itself is rare globally (<2 million cases, mostly West Africa). Category B1 represents a small fraction of incident HIV-2 cases. Estimated <0.05 per 100k globally based on HIV-2 epidemiology.",weak,high,False,,,,
C3887487,Postaxial polydactyly type A,15.0,,incidence,1200000,0.55,True,Postaxial polydactyly,"Postaxial polydactyly type A incidence ~15 per 100k births (1.5 per 10,000 births). Moderate confidence due to birth defect registry data but significant ethnic variation.",moderate,high,False,,Biesecker LG. (2002). Polydactyly: how many disorders and how many genes? Am J Med Genet. 112(3):279-83,https://pubmed.ncbi.nlm.nih.gov/12357473/,literature
C3887524,Skin Erosion,,,,,0.0,False,,"Unmappable - skin erosion is a clinical descriptive term for superficial epidermal loss, not a disease entity. Can result from multiple etiologies (trauma, friction, burns, dermatitis, infections). No systematic epidemiological tracking of this clinical finding.",none,unknown,False,,,,
C3898709,Intestinal-Type Sinonasal Adenocarcinoma,extremely rare,,incidence,extremely rare,0.35,True,Sinonasal Adenocarcinoma,Extremely rare malignancy representing a specific histological subtype of sinonasal adenocarcinoma. Sinonasal adenocarcinomas overall are <1 per 100k; intestinal-type represents a fraction of these. Estimated <0.05 per 100k based on case series literature.,weak,unknown,False,,Barnes L. (2002). Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 10:192-202,,literature
C3899278,Early Rheumatoid Arthritis,28.0,,incidence,2240000,0.8,False,Rheumatoid Arthritis,Reporting incidence of new RA diagnoses. All incident RA cases are by definition 'early' RA at diagnosis. Global incidence approximately 25-30 per 100k person-years based on meta-analyses of population-based studies. Higher in developed countries and females. 'Early' typically refers to disease duration <2 years but incidence captures new diagnoses.,strong,moderate,False,,"Alamanos Y et al. (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 36(3):182-188",https://pubmed.ncbi.nlm.nih.gov/17045630/,literature
C3899655,Childhood Langerhans Cell Histiocytosis,0.5,,incidence,40000,0.7,True,Langerhans Cell Histiocytosis,"Reporting incidence of new diagnoses. Childhood LCH incidence is 4-5 cases per million children per year, approximately 0.5 per 100k overall population when accounting for pediatric demographic proportion.",moderate,low,False,,Stalemark H et al. (2008). Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 51(1):76-81,https://pubmed.ncbi.nlm.nih.gov/18266220/,literature
C3900100,Adult Langerhans Cell Histiocytosis,0.1,,incidence,8000,0.6,True,Langerhans Cell Histiocytosis,"Reporting incidence of new diagnoses. Adult LCH is significantly rarer than childhood form, estimated 1-2 cases per million adults per year, approximately 0.1 per 100k overall population.",moderate,low,False,,,,
C4025886,Severe periodontitis,,11000,prevalence,880000000,0.68,True,Periodontal Diseases,Reporting prevalence for this chronic condition. Global Burden of Disease 2010 study estimates ~11% global prevalence for severe periodontitis (chronic attachment loss ≥6mm). Used as proxy for 2005 era estimates.,strong,moderate,False,2010,Kassebaum NJ et al. (2014). Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 93(11):1045-1053,https://pubmed.ncbi.nlm.nih.gov/25261053/,literature
C4048328,Cervical Cancer,15.3,,incidence,1224000,0.88,False,,Reporting incidence (new cancer diagnoses). GLOBOCAN 2005 data shows cervical cancer global incidence of approximately 15.3 per 100k women per year. High confidence from cancer registry data.,strong,high,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4049446,Neointimal hyperplasia,,,,,0.0,False,,"Pathological process (vessel wall thickening post-intervention), not a primary disease entity. Occurs as complication in 10-50% of stenting/bypass procedures but no population-based incidence surveillance. Not a condition with standard epidemiological tracking.",none,unknown,False,,,,
C4082937,Necrotizing enterocolitis in fetus OR newborn,1.0,,incidence,80000,0.75,False,,"NEC primarily affects premature infants, occurring in 5-10% of very low birth weight infants. Overall incidence is ~0.5-1.0 per 1000 live births. With global birth rate of ~2000 per 100k population per year in 2005, NEC incidence is approximately 1.0 per 100k population per year.",strong,moderate,False,,"Neu J, Walker WA. (2011). Necrotizing enterocolitis. N Engl J Med. 364:255-264",https://pubmed.ncbi.nlm.nih.gov/21247316/,literature
C4086165,Childhood Neuroblastoma,1.0,,incidence,80000,0.88,True,Neuroblastoma,Neuroblastoma is the most common extracranial solid tumor in children. Incidence ~1 per 100k children (10 per million children under 15). Well-documented in pediatric cancer registries.,strong,low,True,2005,"Ries LAG et al. SEER Cancer Statistics Review, 1975-2005",https://seer.cancer.gov/archive/csr/1975_2005/,registry
C4087504,Peritoneal dissemination,,,,,0.0,False,,"Peritoneal dissemination is a metastatic process/finding, not a primary disease entity. Occurs as secondary manifestation of various cancers (ovarian, gastric, colorectal, pancreatic). Cannot assign meaningful incidence without specifying the primary malignancy.",none,unknown,False,,,,
C4284013,Primary cholangiocarcinoma of intrahepatic biliary tract,0.85,,incidence,68000,0.72,True,Cholangiocarcinoma,Intrahepatic cholangiocarcinoma incidence ~0.85 per 100k globally from cancer registries. Second most common primary liver malignancy after HCC. Rising incidence noted in Western countries.,moderate,high,False,2005,Khan SA et al. (2005). Cholangiocarcinoma. Lancet. 366(9493):1303-1314,https://pubmed.ncbi.nlm.nih.gov/16214602/,literature
C4317224,Congenital disorder of glycosylation type 1q,extremely rare,,incidence,extremely rare,0.35,True,Congenital Disorders of Glycosylation Type 1,Extremely rare genetic disorder (CDG-1q/SRD5A3-CDG) with <100 cases reported worldwide. Estimated <0.01 per 100k births based on case report frequency. No systematic population-based epidemiological data available.,weak,unknown,False,,Cantagrel V et al. (2010). SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell. 142(2):203-17,https://pubmed.ncbi.nlm.nih.gov/20637498/,literature
C4520843,Pterygium of eye,8.0,,incidence,640000,0.52,False,Pterygium,"Pterygium of eye (conjunctival growth onto cornea) incidence estimated ~8 per 100k globally. High geographic variation based on UV exposure, ranging from <1% prevalence in temperate zones to >20% near equator. Limited population-based incidence data.",moderate,high,False,,,,
C4520983,Congenital atresia of extrahepatic bile duct,0.7,,incidence,56000,0.72,False,,"Reporting incidence of biliary atresia at approximately 0.7 per 100k births (1 in 8,000-15,000 live births). Global incidence shows geographic variation with higher rates in East Asia.",strong,high,False,,Chardot C et al. (2006). Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 31(6):1006-13,https://pubmed.ncbi.nlm.nih.gov/10604573/,literature
C4551675,"Keratoderma, Palmoplantar",2.0,,incidence,160000,0.45,False,,"Palmoplantar keratoderma (PPK) encompasses hereditary and acquired forms. Estimated ~2 per 100k based on dermatology registry data, but systematic epidemiological studies are limited.",weak,moderate,False,,,,
C4551687,Sarcoma of soft tissue,4.0,,incidence,320000,0.78,False,,"Soft tissue sarcomas globally: ~4 per 100k per year based on SEER and international registry data circa 2005. Includes all histological subtypes (liposarcoma, leiomyosarcoma, UPS, etc.).",strong,low,True,2005,"Toro JR et al. (2006). Incidence patterns of soft tissue sarcomas in the SEER program, 1978-2001. Int J Cancer. 119(12):2922-30",https://pubmed.ncbi.nlm.nih.gov/17013893/,literature
C4551961,Familial Isolated Hyperparathyroidism,0.05,,incidence,4000,0.35,True,Hyperparathyroidism,"Rare genetic form of hyperparathyroidism. Estimated <0.1 per 100k based on case series. Primary hyperparathyroidism overall affects ~25 per 100k, but familial isolated form represents <1% of cases.",weak,unknown,False,,,,
C4721610,"Carcinoma, Ovarian Epithelial",5.4,,incidence,432000,0.82,True,Ovarian Cancer,"Epithelial ovarian carcinoma comprises ~90% of ovarian cancers. Global ovarian cancer incidence ~6 per 100k women (GLOBOCAN 2005), epithelial subset ~5.4 per 100k women or ~2.7 per 100k general population. Adjusted for women-only denominator.",strong,moderate,True,2005,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry
C4721779,Ovarian cancer stage IV,2.2,,incidence,176000,0.55,True,Malignant neoplasm of ovary,Stage IV ovarian cancer represents approximately 30-35% of ovarian cancer diagnoses at presentation. Derived from overall ovarian cancer incidence (6.6) × stage distribution (0.33) = ~2.2 per 100k women. Lower confidence due to indirect calculation.,moderate,moderate,False,,SEER Cancer Statistics Review (stage distribution data combined with GLOBOCAN incidence),https://seer.cancer.gov/,registry
C4722085,Malignant neoplasm of colon and/or rectum,35.2,,incidence,2816000,0.9,False,,Reporting incidence (new diagnoses). Synonymous with colorectal carcinoma. GLOBOCAN 2002 data shows global incidence ~35 per 100k. Strong cancer registry data worldwide.,strong,high,False,2002,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
C4727169,Metastatic Gastric Carcinoma,7.5,,incidence,600000,0.68,True,Gastric Carcinoma,"Gastric cancer global incidence ~15 per 100k in 2005. Approximately 50% of gastric cancers present with metastatic disease at diagnosis, yielding ~7.5 per 100k for metastatic gastric carcinoma. Geographic variation is high (East Asia >> Western countries).",moderate,high,True,2005,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature
